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Singapore grouper iridovirus (SGIV) is a major pathogen that causes 
significant economic losses in grouper aquaculture. The virus contains a 
dsDNA genome of about 140kb predicted to encode 162 open reading frames 
(ORFs). In this project, we demonstrated that suppression of ORF075R 
expression, an abundant viral structural protein, can result in a significant 
reduction of viral infectivity in grouper embryonic cells. We also revealed that 
ORF075R had four distinct protein isoforms with slightly different molecular 
mass and pI. The post-translational modification of ORF075R was due to 
phosphorylation. The phosphorylation sites were characterized by MS. In 
addition, the phosphorylation profiles of ORF075R changed in different 
phases of SGIV infection. ORF075R was localized in the host cell cytoplasm. 
We hypothesize that multi-phosphorylation of ORF075R may play different 
roles in viral morphogenesis and viral-host interaction. We have attempted to 
crystallize this protein or its truncated fragments without success. The protein 
crystallization work may help us to further investigate the structure and 
function of ORF075R. 
This study was the first report to study the alteration of protein expression in 
SGIV infected zebrafish cell line instead of the grouper cell line. Many novel 
zebra fish proteins have been identified. The proteomic results therefore 
provided vast valuable information for host cells response to SGIV infection.  
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1.1 Overview of viruses and DNA viruses  
Viruses, which mean poisons and toxins from the Latin, are microorganisms 
that can only grow and reproduce in the host cells (either prokaryotes or 
eukaryotes).  
In 1898, the first clue on the nature of virus was discovered by Friedrich 
Loeffler and Paul Frosch. In their study of foot-and-mouth disease, these 
investigators found that the cause of this disease in livestock was an infectious 
particle smaller than any known bacteria. Later on, it was demonstrated that 
each viral particle carries a small amount of genetic material (either DNA or 
RNA), coated by a protective protein (or protein and lipids) named capsid. 
Outside the capsid, tails or envelops can be found in some types of viruses 
(Knipe and Howley, 2001).   
Viruses can be classified into DNA viruses and RNA viruses based on their 
genome compositions. DNA viruses can be further classified into 
single-stranded DNA (ssDNA) viruses and double-stranded DNA (dsDNA) 
viruses. RNA viruses can also be classified as double-stranded RNA (dsRNA) 
viruses, negative or positive single-strand RNA (ssRNA) viruses. The family 
of iridovirus is one of the dsDNA viruses in more than 30 dsDNA viruses’ 
families (Andrew et al., 2011). 
1.2 Overview of Iridoviridae family  
The name of Iridoviridae was derived from Iris, who is the goddess of 
rainbow in Greek mythology. Iridovirus can cause the iridescent phenomenon 
when light reflected from the surface of viruses crystalline arrays in host 
cytoplasm interferes with newly arriving light (Klug et al., 1959).  
The family of iridovirus has an icosahedral (20-sided) capsid, which are 
around 120 to 300 nm in diameter. The viruses possess an internal lipid 
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membrane located between the viral core and outer capsid. In the virus capsid, 
the viral core contains a double-stranded DNA genome with unique structure 
of terminal redundancy and cyclic permutation (Chinchar et al. 2009). 
1.2.1 Classification of Iridoviridae family   
In 1954, Smith and Xeros found the first iridovirus in insects (Smith and 
Xeros, 1954). From literatures, more than 100 species of iridoviruses have 
been discovered. Iridovirids infect a broad range of hosts including 
invertebrates and poikilothermic vertebrates, and cause systemic diseases.  
Classification of the family Iridoviridae is based on their host species, genetic 
properties and morphological characters. The family Iridoviridae is currently 
classified into five genera: Iridovirus, Chloriridovirus, Ranavirus, 
Megalocytivirus and Lymphocystivirus. Hosts of the first two genera come 
from invertebrates (flies, silkworms and mosquitoes). For the viruses which 
are smaller than 140 nm in diameter, are classified into genus Iridovirus. 
While the larger viruses which are around 180 nm in diameter, are classified 
into genus Chloriridovirus. The last three genera can infect poikilothermic 
vertebrates including amphibians, reptiles and fish (Chinchar et al., 2005). 
However, there are still few isolates that have not been characterized to any 
genera. The current classification of the family Iridoviridae is showed in Table 
1.1. 
Ranavirus is a large genus contenting many isolates that can infect frogs and 






Table 1.1 Taxonomy of the family Iridoviridae 
Genus Viral species Tentative species 
Iridovirus 




virus (AGIV), IIV–2, 
–9, –16, –21, –22, 
–23, –24, 29, –30, 
–31  
Chloriridovirus Invertebrate iridescent virus 3 
(IIV–3) 
 
Ranavirus Frog virus 3 (FV3), [tadpole 
edema 






 Ambystoma tigrinum virus 
(ATV), 




Bohle iridovirus (BIV) 
 
 Epizootic haematopoietic 
necrosis virus (EHNV) 
 
 European catfish virus (ECV) 
[European sheatfish virus, ESV] 
 
 Santee-Cooper ranavirus, 
[Largemouth bass virus, LMBV; 
doctor fish virus, DFV; guppy 
virus 6, GV–6] 
 
 
Megalocytivirus Infectious spleen and kidney 
necrosis virus (ISKNV) [Red sea 
bream iridovirus, RSIV; African 
lampeye iridovirus, ALIV; 
Orange spotted grouper 
iridovirus, OSGIV; Rock bream 
iridovirus, RBIV] 
 
Lymphocystivirus Lymphocystis disease virus 1 
(LCDV–1) LCDV–2, LCDV-C, 
LCDV-RF 
 






1.2.2 Characteristics of Iridoviridae family   
From the previous review, there are three key elements in iridovirus viral 
particle: protein capsid, lipid layer and DNA core. The family of iridovirus has 
an icosahedral capsid, which are around 120 to 300nm in diameter. The major 
component of the virus capsid is a major capsid protein (MCP) around 50 kDa. 
Members of the same viral genus show more than 70% similarity at the amino 
acid level, whereas species from different genera show less than half similarity 
(Do et al. 2005a, 2005b) 
The lipid bilayer, 4 nm thick, is closely associated with an additional inner 
shell beneath the fused layer of the capsid. A highly hydrated DNA core is 
surrounded by the lipid component. The DNA core and virus capsid appear to 
be connected by intermembrane proteins passing through the lipid layer 
(Chinchar et al., 2009). Phospholipid is the main component of the lipid layer. 
It is a meaning part for the vertebrate iridoviruses infection (Berry et al., 1983; 
Speare and Smith, 1992).  
A highly hydrated core which contains a linear dsDNA molecule and protein 
components is located inside the viral capsid. The size of the dsDNA is 
between 100 to 210 kbp. The viral core can be observed under electron 
microscope after negative staining due to their high electron-dense nature 
(Cuillel et al., 1979).  
In some cases, viruses were surrounded by an outer envelope which was 
acquired by budding through the host membranes. This envelope is not a 
compulsory requirement for infectivity, but the envelope coated viruses have a 
higher specific infectivity, likely owing to the presence of specific receptor 
proteins within the viral envelope (Gendrault et al. 1981; Braunwald et al. 
1979). Fibrillar structures have also been reported protruding from capsid 
subunits of Lymphocystis disease virus 1, Megalosystisivrus and 
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Chloriridovirus (Williams et al., 2006). 
1.2.3 Replication cycle of Iridoviridae family 
Iridovirus replication is unique and involves both nuclear and cytoplasmic 
compartments. The process was summarized in Figure 1.1. In current results, 
the FV-3 is the main model of iridovirus replication study. Both enveloped 
virus and naked virus can infect the host cells, but may trigger different 
receptors. The lipid envelope should help the viral particles entering the host 
cells via receptor mediated endocytosis, while the naked viral particles may 
fuse with the plasma membrane and uncoat their capsid. The first stage of viral 
DNA synthesis occurs in the host cell’s nucleus. Two types of viral genes, the 
immediate early (IE) and delayed early (DE) genes are replicated. Most of 
these genes encode the regulatory proteins and catalytic enzymes such as viral 
DNA polymerase and viral homologs of cellular RNA polymerase II. The 
second stage of viral DNA synthesis occurs in the host cell’s cytoplasm, and 
the DNA polymerases which synthesis and translation in the first stage were 
used in this stage. During replication, multiple copies of a hypothetical viral 
genome form a concatameric structure which is more than ten times larger 
than genome-sized unit (Goorha 1982). This unique structure form terminal 
redundancy in virus assembly which means a single virus contains an entire 
genome and duplicated copies of some genes. In all the invertebrate iridovirus, 
the viral DNA is not methylated, while they are all methylated in vertebrate 
iridovirus except SGIV (Song et al., 2004). In late infection stage, a huge viral 
assembly sites (AS) can be found in host cell cytoplasm. The viral particles 
form a paracrystalline array in assembly sites. Most of the mature viruses are 
uncoated (no envelope) and release from the host cells following cell lysis 











1.3 Significances and research progress of Singapore Grouper Iridovirus 
(SGIV) 
1.3.1 Introduction of SGIV 
Singapore Grouper Iridovirus (SGIV), a large dsDNA virus, is a member of 
Ranavirus genus, Iridoviridae family. This virus is a causative pathogen of a 
serious systemic disease “Sleepy Grouper Disese” (SGD) in brown-spotted 
grouper fish (Epinephelus tauvina). 
This virus was first reported in 1994, causing significant economic losses in 
Singapore marine net cage farm (Chua et al., 1994). This disease, with 
symptoms of enlargement of cells, necrosis of the renal and splenic 
hematopoietic tissues, could cause 30% to 100% morality in grouper fry. In 
1998, this virus was isolated from brown groupers (Qin et al., 2001). 
SGIV genome was fully sequenced in 2004, and 162 open reading frames 
(ORF) was predicted based on the genomic sequence. Many of these ORFs are 
novel with unknown function (Song et al., 2004). With the availability of a 
grouper cell line (Chew-Lin et al., 1994), SGIV is an ideal model to study the 
molecular mechanism and virus-host interaction of the larger DNA viruses 
1.3.2 Research progress on SGIV 
1.3.2.1 Structure of SGIV 
SGIV virus particles can be purified from infected grouper embryonic cell line 
(GEC) by ultracentrifugation using sucrose gradient following by iodixanol 
gradient. The majority of virus particles were suspended at the boundary layer 
between 40% and 50% sucrose, or 30% and 40% iodixanol. The viruses’ 
pictures have been collected on a 300 kV Titan Krios electron 
cryo-microscopy. In total 20,195 particle images were collected by cryo EM. A 
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final 9.7 Å cryo-EM structure was reconstructed (Fig. 1.2 A) from 9,535 
particle images. The resolution was measured based on Fourier Shell 
Correlation (FCS) =0.5 criterion from two half sets of data.  There were 
2,460 trimeric hexamers and 12 pentamers distributed on the T= 247 









Figure 1.2 SGIV’s molecular architecture at 9.7 Å resolution (Tran et al., 
unpublished data) 
(A) The surface representation of SGIV cryo-EM structure at 9.7 Å resolution, 
T=247. There were 60 copies of pentamers, one at each vertex, and 14760 
copies of hexamers per one capsid. (B) The trimeric hexamer and the pentamer 




1.3.2.2 Genome sequence and proteomics analysis of SGIV 
The complete genome of SGIV has been sequenced and deposited at NCBI 
data base in 2004. Random shotgun and restriction endonuclease genomic 
techniques were used in this genomic project. The total SGIV genome consists 
of 140,131 nucleotide base pair with 162 predicted ORFs (Song et al., 2004). 
In the past 10 years, a total of 67 viral proteins have been confirmed by 
different approaches such as peptide mass finger prints, 1-DE-MALDI, 
LC-MALDI and iTRAQ analysis in our group (Song et al., 2004, Song et al., 
2006, Chen et al., 2008). However, the identify and function of more than 100 
ORFs remain unknown. 
The differential proteomes of GEC with and without SGIV infection were 
studied by iTRAQ analysis as well. In this study more than 700 host proteins 
were recognized and classified, 14 host proteins were up regulated and 5 host 
proteins were down regulated after SGIV infection. These proteins are related 
to DNA replication, genomic package, ATP synthesis, protease inhibition, and 
ubiquitination (Chen et al., 2008). 
1.3.2.3 Temporal and differential stage gene expression of SGIV  
To study the temporal gene expression in SGIV, a DNA microarray was 
generated for the SGIV genome. Comparing the viral genes between the 
noninfected and infected host cells at different time course, these genes can be 
classified to three different stages: immediate early, early and late genes. 
Real-time RT-PCR analysis was used to confirm this DNA microarray data 
(Chen et al., 2006). These results provide important insights into the 
replication and pathogensis of SGIV.  
1.3.2.4 Lipidomic study of intracellular SGIV  
The lipid compositions are essential elements in iridovirus, however the 
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function of such unenveloped intracellular viruses remain unknown. Over 220 
lipid species from the virus and host cells were identified and quantified by 
electrospray ionization mass spectrometry. Five capsid proteins (ORF26R, 
ORF075R, ORF089L, ORF090L, and ORF101R) were demonstrated to be 
lipid-binding proteins (Wu et al., 2010). These results should facilitate further 
studies of the SGIV and other iridoviruses. 
1.3.2.5 Significance of SGIV structural protein ORF075R 
A novel structural protein ORF075R is the major research target for this thesis. 
This protein is a late gene protein in SGIV, which means it is a structural 
protein in virus particle. The size of this protein is around 20 kd, and the pI is 
4.5. It had four protein isoforms in normal infected cells and may be involved 
in virus protein phosphorylation. What is more, ORF075R showed specific 
binding to particular lipids. It may enrich certain lipid molecules in viral 
particles and be involved in viral assembly (Wang et al., 2008; Wu et al., 
2010). 
1.4 Introduction to Morpholino oligonucleotides technology 
1.4.1 Gene knockdown  
Gene knockdown refers to the techniques in which the expression of one or 
more of an organism's genes is reduced through genetic modification or 
reagent treatment.  The knockdown reagent such as a short DNA or 
RNA oligonucleotide with a sequence complementary to either an mRNA 
transcript or a gene can cause a temporary change in gene expression without 
modification of the chromosomal DNA and is referred to as a "transient 
knockdown". There are three major gene knockdown techniques: the 
phosphorothiotate-linkd DNA (S-DNA), short interfering RNA (siRNA), and 




Figure 1.3 structures of three types of gene knockdown reagents 
Three major gene knockdown techniques: the phosphorothiotate-linkd DNA 




1.4.2 Gene knockdown by Morphlino 
1.4.2.1 Morphlino technology 
Morphlino refers to an artificial chemical containing a six-membered 
morpholine ring. Antisense morphlino (asMO) is a transient gene knockdown 
reagent which is usually 25 bases in length and each subunit contains a 
nucleotide base (adenine, cytosine, guanine or thymine), a 6-membered 
morpholine ring and a non-ionic phosphorodiamidate inter-subunit linkage 
(Figure 1.3). 
1.4.2.2 Mechanism of asMO knockdown 
AsMO was first applied in zebrafish developmental biology (Nasevicius and 
Ekker, 2000), and recently it was widely applied in antivirus research (Stein et 
al., 2001). AsMO can bind to the 5'-untranslated region of messenger RNA 
(mRNA), interferes with progression of the ribosomal initiation complex from 
the 5' cap to the start codon. AsMO also can interfere 
with pre-mRNA processing steps. To ensure the efficacy of asMO, the reagent 
must be delivered to the cytosol of target cells. Electroporation is one of the 
useful methods. It has been proven that morpholino could effectively inhibit 
the proliferation and growth of both RNA virus and DNA virus (McCaffrey et 
al., 2003, Sample et al., 2007). 
1.4.2.3 Advantages of asMO 
AsMO has become a standard knockdown tool in animal embryonic systems, 
because of its high specificity, stability and lack of non-antisense effects. The 
standard size 25 bases of asMO causes a higher affinity of the complementary 
RNA sequences than other two types of gene knockdown platforms. Because 
of their completely unnatural backbones, asMOs are not recognized by cellular 
proteins. Nucleases do not degrade asMOs (Hudziak et al., 1996). 
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Morpholinos do not activate toll-like receptors and so they do not active innate 
immune responses such as interferon induction or the NF-κB mediated 
inflammation response. Morphlinos are not known to modify methlylation of 
DNA. 
1.5 Introduction to Proteomics  
1.5.1 Proteomics technology  
Proteomics is the large-scale study of proteins, particularly their structures and 
functions. The word "proteomics" was created to make an analogy with 
genomics. The word "proteome" is blend of "protein" and "genome" 
(Anderson and Anderson, 1998). Proteome of an organism is the set of 
proteins produced by it during its life, while genome is its set of genes. 
Proteomics is often considered more complex than genomics, as the proteome 
differs from cell to cell in an organism’s while the genome is stable. For this 
reason, proteomics is concerned with the systematic, large-scale analysis of 
proteins. Proteomics can be seen as a mass-screening approach to molecular 
biology, which aims to document the overall distribution of proteins in cells, to 
identify and characterize individual proteins changes, and ultimately to 
elucidate their functional relationships (Twyman, 2004). 
The different proteomics platforms can be separated into protein separation, 
protein identification, protein quantification, and protein modification, etc. A 
few of these platforms will be discussed in the following sections. 
1.5.2 The platforms of proteomics 
1.5.2.1 Protein separation 
To better integrate with subsequent proteomics techniques, and to characterize 
the individual protein components, it is important to separate the complex 
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proteins sample to individual proteins. The one dimensional electrophoresis 
(1-DE), two dimensional electrophoresis (2-DE) and liquid chromatography 
(LC) are three widely used methods. The first two methods are gel-based 
protein separation, the last one is the non-gel-based method. 
1.5.2.2 Protein identification 
Mass spectrometry (MS) is an analytical technique that measures 
the mass-to-charge ratio of charged particles (Sparkman, 2000). MS technique 
can be used to identify unknown compounds, determine the 
isotopic composition of elements in a molecule, and determine the structure of 
a compound by observing its fragmentation.  A mass spectrometer consists 
three sections as showed in Figure 1.4: i.e. the ionization source, the analyzer 
and the detector. The electrospray ionization (ESI) and matrix assisted laser 
desorption ionization (MALDI) are the two common methods of 
ionization.  Many mass spectrometers use two or more mass analyzers 
for tandem mass spectrometry (MS/MS). This technique is used to identify the 











1.5.2.3 Protein quantification 
The objective of quantitative proteomics is to obtain quantitative information 
about all proteins in a sample. This technique not only can identify certain 
proteins, but also can compare the proteins yields in different samples. 
Isotope-coded affinity tags (ICATs) and Isobaric Tags for Relative and 
Absolute Quantification (iTRAQ) are two types of methods for quantitative 
proteomics which rely on chemical labeling reagents (Gygi et al., 1999). ICAT 
platform can only be used to evaluate two samples, while iTRAQ platform can 
compare up to 8 different samples at the same time.  
1.5.3 Introduction to Isobaric Tags for Relative and Absolute 
Quantification (iTRAQ) 
Isobaric Tags for Relative and Absolute Quantification (iTRAQ) is a 
non-gel-based technique used to quantify proteins from different sources in a 
single experiment. This technique was firstly developed by Darryl Pappin and 
colleagues at Applied Biosystems in 2004 (Ross et al., 2004). It can be used to 
label four samples simultaneously. Nowadays, the new generation of eight 
channel iTRAQ has been developed which enhances the reproducibility and 
confidence of the information. 
1.5.3.1 Mechanism of iTRAQ 
The main principle of the methodology is a multiplex set of isobaric reagents 
which consist of an active ester (NHS) moiety and an isobaric tag for reaction 
with the N-terminal amino groups of peptides and the amino groups of lysine. 
Furthermore, the isobaric tag consists of a balance group and a reporter group. 
In the 4-plex iTRAQ system, the overall mass of each reagent is 145 Da. The 
mass of charge reporters are from 114 to 117 Da. However in the 8-plex 
iTRAQ system which showed in Figure 1.5, the overall mass is 305 Da, and 
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the reports mass are from 113 to 121 Da (except 120 Da) 
(http://www.theravalues.com/prototype/english/services/pro_itraq.html). This 
principle allows the peptide reactive group to label all peptides thus enhancing 
peptide coverage for any sample. 
Same amount of control/treated samples are reduced, alkylated and digested 
with protein enzyme (trypsin) individually, and labeled with distinct iTRAQ 
reagents. Proteins in different samples are mixed before analyzed by 
LC-MS/MS. Identical peptides derived from different samples have the same 
mass. However, in MS/MS analysis, the signal intensity ratios of the reporter 
groups indicate the ratios of the peptide quantities and can be used to 
determine the relative quantities of the peptides. The workflow of iTRAQ 


















1.5.3.2 iTRAQ approach in virus proteins functional study 
In the past years, iTRAQ technology was developed quickly combined with 
multidimensional liquid chromatography and mass spectrometry technologies. 
It enables the researchers to easily identify the dynamics of proteins profiles in 
many complex biological processes. 
Because of the high sensitivity and accuracy, iTRAQ technology is also used 
as a powerful high throughput method in the study of viral proteins. Compare 
to other proteomics approaches such as gel-based electrophoresis, more 
proteins can be identified by iTRAQ platform (Li et al., 2007). RT-PCR and 
western blot are the two major downstream techniques to confirm iTRAQ 
analysis data. ITRAQ also can be used to determine the sub cellular 
localization of viral proteins.  
Our laboratories have used iTRAQ technology to identify SGIV viral proteins 
from infected grouper embryonic cells (GEC) (Chen et al., 2008). Forty-nine 
viral proteins were recognized, of which 11 were identified for the first time. 
At the same time, 743 host proteins were revealed. Moreover, our group also 
used iTRAQ technology to study the function of one single viral protein, 
ORF0158, function by combining with antisense morpholino oligo 
knockdown platform (Tran et al., 2011). However, the lack of the complete 
genome sequences of the host cell line (i.e. grouper fish) limited the host 
proteins identification. 
1.5.4 Protein modification 
To study the protein modification, special methods have been approaches to 
enrich the modified forms. Phosphoproteomics and glycoproteomics are two 




1.6 Zebrafish as a popular model  
The zebrafish (Danio rerio), a small tropical fresh-water fish (teleost), which 
lives in rivers of northern India, northern Pakistan, Nepal, and Bhutan in South 
Asia, has emerged as a major model organism for various biological 
researches.  
Compared to other models, the zebrafish provides distinct advantages. Firstly, 
its rapid external development and optical clarity facilitate in vivo observation 
throughout the embryonic stages. Secondly, continuous high fecundity of adult 
fish provides plentiful materials for various experimental manipulations. 
Thirdly, rapidly expanding resources in genome sequencing, genetic and 
physical mappings, and gene expression profiling provide the tools necessary 
for molecular analysis. More recently, the zebrafish has also been employed in 
applied investigations such as the study of human diseases (reviewed by 
Lieschke and Currie, 2007), drug discovery (reviewed by Zon and Peterson, 
2005) and environmental biomonitoring (Alestrom et al., 2006). Moreover, the 
genetic tools such as knock down by antisense morpholino oligo and 
transgenic approach can be applied in zebrafish as well. 
As a powerful model in biological researches, zebrafish is also a suitable 
material in our experiment. To further study SGIV virus-host interaction, 
proteomics approaches were used to detect the proteins expression level in 
both virus proteins and host proteins. In our previous studies, the GEC were 
used as the host cell line in these experiments. However, the entire genome of 
grouper is still unknown, which largely limits protein identification. The 
Sanger Institute started the zebrafish genome sequencing project in 2001 and 
has released several genome assemblies, the latest being Zv9 (released on Nov 
10th 2010) (http://www.sanger.ac.uk/Projects/D_rerio/). The zebrafish cell 
line (ZC), used in this study was derived from stem cells, and was established 
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in Prof. YH. Hong’s lab at NUS, and was maintained in EMS4 medium. 
(Hong’s unpublished data). 
1.7 Objective of this study  
In view of the above review, previous studies of SGIV in our lab have focused 
on viral genes expression and classification. By using genome sequencing and 
DNA microarray analysis, important data have been found. However, the 
information about SGIV novel genes functions and viral/host interaction are 
still limited. Therefore, many questions about this virus infection and 
replication mechanism remain unknown. 
The first objective of this thesis is to investigate the functions of a novel 
protein SGIV ORF075R. To study this novel protein’s function, asMO gene 
knockdown platform and proteomics approaches were used. Meanwhile, 
another important SGIV structural protein ORF018R was used as a control 
due to their functional similarity. 
The second objective is to discover the host proteins which are up or down 
regulated in SGIV infection. The iTRAQ technique was performed followed 
by LC-MS/MS. Compare to previous experiment using grouper cell line as the 
host cells, while in this thesis zebrafish cell line was used to enlarge the host 
protein database. Few key proteins such as ORF075R, ORF018R, and 
ORF158 were selected and knocked down in this comparison.  
Last but not the least, to further investigate the structure and function of SGIV 
novel protein ORF075R, we have attempted to purify the viral proteins and to 
crystallize the protein. 
In summary, our aims are to discover the functions and structure of SGIV 
ORF075R, and to study the protein-protein interactions involved the 
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ORF075R is a late gene protein in SGIV, and it is a novel structural protein in 
virus particle. The size of this protein is around 20 kd, and the pI is 4.5. The 
study of this protein was quite limited. As an abundant structural protein in 
virus particle, ORF075R should play an important role in SGIV assembly and 
infection. In this chapter, the function of this protein was investigated by 
multiple methods.  
2.2 Materials and Methods 
2.2.1 Cells and viruses 
Grouper embryonic (GE) cell line was isolated from the brown-spotted 
grouper (Epinephelus tauvina) (Chew-Lim et al., 1994). The Eagle’s minimum 
essential medium (10% fetal bovine serum, 0.116 M NaCl, 100 IU of 
penicillin G/ml and 100uL of streptomycin sulfate/ml) was used to culture the 
GE cells at 27℃.  
Singapore Grouper Iridovirus (SGIV) was isolated from diseased grouper (Qin 
et al., 2003). GE cells should reach an 80% confluence of a monolayer in fresh 
EMEM culture medium and were infected with SGIV at a multiplicity of 
infection (MOI) of 1. The culture medium containing virus was harvested at 
48h postinfection (p.i.). Appropriate medium containing SGIV was collected 
and divided into groups as seeds and stored at -80℃ (Song et al., 2004). 
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2.2.2 AsMO design and transfection  
AsMO design was based on the full sequenced genome and predicted 
ORF075R and ORF018R sequences (Song et al., 2004). Moreover, the 
sequences were screened with BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) 
against the whole SGIV database to preclude any unintentional gene-silencing 
effects. Negative-control asMO is the standard control oligo from GeneTools. 
All asMOs were synthesized and purified by GeneTools. The designed asMOs 
were listed in Table 2.1 
Table 2.1 Designed asMOs 
Knockdown target Synthesized asMO Target location 
Control CCTCTTACCTCAGTTACAATTTATA  
ORF018R GCGTTCAGATAGTTTTACGGACATC -1-- +24 
ORF075R CTCCGAAAATATCGTCGATATCCAT 0--+25 
AsMOs were delivered using Nucleofactor® kit T (Amaxa), program T27. In 
brief, the fresh GE cells were trypsinized and spun down, then washed with 
PBS, resuspended in 100 μL mixture of 2 μL of asMOs (final concentration: 
20 μM) and 98 μL of nucleotransfector solution (with supplement), transferred 
into a cuvette for electrophoresis. The mixture was immediately resuspended 
with fresh medium and transferred into the cell culture flask, and cultured in 
normal condition.  
SGIV was inoculated into the tranfected cells at 40 hours post transfection. 
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Infected GE cells were harvested at 48 hpi for downstream analysis or at 
different time courses for transmission electron microscopy experiment and 
Tissue Culture Infectious Dose 50 (TCID50 test). 
2.2.3 Viral Protein Analysis  
SGIV-infected GE cells were collected, pelleted, and resuspended in PBS. 
Cells pellet were lysed by RIPA lysis buffer (25 mM Tris•HCl pH 7.6, 150 
mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS), samples were 
sonicated and incubated on ice for 30 min. After that, lysates were centrifuged 
at 4 ℃ and quantified with Coomassie Protein Assay kit (Pierce). The samples 
were aliquoted and stored in -80 ℃ for downstream experiments. 
2.2.4 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed following Laemmli’s method (Laemmli, 1970). Discontinuous 
SDS-PAGE with a stacking gel (5 % acrylamide/Bis solution 0.125 M 
Tris-HCl pH 6.8, 0.1 % SDS), and separating gel (12 % acrylamide/Bis 
solution, 0.375 M Tris-HCl pH 8.8, 0.1 % SDS) was performed in 1X SDS 
running buffer (20 mM Tris Base, 200 mM glycine, 0.1 % SDS) at 80 volts for 
30 min followed by 150 volts. After running, the gel was stained in Coomassie 
staining buffer (20 % methanol, 10 % acetic acid and 0.1 % Coomassie 
Brilliant Blue R-250) for 20 min, and then destained with a destaining solution 
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(20 % methanol, 10 % acetic acid). 
2.2.5 Western blot assay 
The protein samples were separated in SDS-PAGE gel as described in 2.2.3 
and transfered onto a Polyvinylidene fluoride (PVDF) membrane (Bio-rad) in 
blotting buffer (3.205g Tris base, 14.25g glycine and 200ml methanol per liter) 
at 80 Voltage for 80 min in 4 ℃. The blotted membrane was then blocked in 3% 
BSA in TBST (20 mM Tris pH 7.4, 154 mM NaCl, 0.1% Tween 20) for 1 hour. 
Then the membranes were treated with the primary antibodies (anti viral 
protein antibodies) for 1 hour, washed with 3X10 min TBST, incubated with 
the secondary antibody (Goat Anti-Rabbit IgG, HRP Conjugate) for 1 hour, 
washed 3X10 min with TBST. After that, the membrane was immersed in a 
mixture of peroxide solution and luminal enhancer solution (Pierce) for film 
exposure and image development. 
The purified ORF018R and ORF075R were used to produce the rabbit 
anti-ORF018R and anti-ORF075R polyclonal antibodies. The monoclonal 
antibody (MAb) to actin was from Chemicon. Horseradish 
peroxidase-conjugated donkey anti-mouse and donkey anti-rabbit polyclonal 
antibodies were from Pharmacia. 
2.2.6 TCID50 test 
The asMOs transfected GE cells were infected with SGIV at 40 hpt at MOI of 
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1. The asMOs cells with control cells culture supernatant and cell pellet were 




and used to infect GE cells 
with eight repetitions per dilution to perform the TCID50 assay. The viral titres 
were calculated using the Spearman-Karber method (Hamilton et al., 1977). 
2.2.7 Transmission electron microscope 
The GE cells were harvested and fixed in 2.5 % glutaraldehyde, 2 % 
paraformaldehyde in 1X PBS (pH 7.4) overnight. Then the samples were 
post-fixed with 1 % Osmium tetroxide for 3 hours, followed by dehydration in 
an ethanol series of 50 %, 75 % and 100 % (twice). The samples were 
embeded using the Spurr kit (Sigma), sliced into ultra thin sections (70-90 μm) 
and stained with 2 % uranyl acetate, 1 % lead citrate. The ultra thin sections 
were viewed under the JOEL JEM 2010F electron microscopy. 
2.2.8 Virus purification  
The SGIV infected GE cells and growth medium was harvested at 72 hrs p.i. 
and centrifuged at 12, 000 × g for 30 min at 4℃. The resulting pellet was 
resuspended with the culture medium and ultrasonicated. The suspension 
containing the lysate, viral particles and cellular debris was then centrifuged at 
4,000 × g for 20 min at 4℃. The supernatant was layered onto a cushion of 35% 
sucrose and centrifuged at 210,000 × g for 1 h at 4℃. The pellet was 
resuspended with the TNE buffer (100 mM Tris; 2.0 M NaCl; 10 mM EDTA; 
pH 7.4) and overlaid with 30%, 40%, 50% and 60% (m/v) sucrose gradients 
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and centrifuged at 210,000 × g for another 1 h at 4℃ Viral bands, present 
between 40% and 50% sucrose, were aspirated, sonicated briefly, and reloaded 
onto iodixanol gradients (10%, 20%, 30%, and 40%) and centrifuged for at 
350,000 × g for 16 hrs at 4℃. Virus particles were suspended at the boundary 
layer between 30% and 40%. This layer was individually aspirated and spun 
down at 100,000 × g. The virus particles were stored at -80℃. 
2.2.9 Immunofluorescence (IF) assay 
GE cells were cultured to 90% confluence on Lab-Tek
®
 Chambered 
Coverglass (Nalge Nunc), infected with SGIV with an MOI of 1. Cells were 
fixed at 36 h p.i. with 3% paraformaldehyde, permeabilized with 100% 
methanol, and then incubated with anti-ORF075R antibody (1:500) for 1 hr, 
washed with 3X10 min in TBST. Cells were incubated in anti-rabbit 
AlexaFluor488-conjugated antibody for 1 hr, washed with 3X10 min in TBST. 
DsDNA were stained with Hoechst (Invitrogen). Fluorescence was detected 
with a Zeiss confocal microscope.  
2.3 Results  
2.3.1 ORF075R knockdown experiments 
2.3.1.1 Effect of knock down on SGIV and host proteins expression 
Previous work in our lab has established a platform to study SGIV by 
antisense morpholino oligonucleotide (asMO) knockdown technology (Wang 
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et al., 2008).  




 were infected with SGIV at MOI 
of 1 at 24h post-transfection. Total cell lysates were prepared at 48h 
post-infection. The antibody against ORF075R was used to analyze the 
knockdown efficiency. The actin was used as an internal control. The result 








 knockdown effects checked by Western blot assay 




 were infected with SGIV (MOI=1) 
at 24h post-transfection. Total cell lysates were prepared at 48h p.i. 
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As can be seen, only a weak band was shown in the knockdown sample. This 
figure clearly showed that the expression level of ORF075R in infected GEC 
was significantly decreased after asMOs transfection. Our knockdown 
experiment was successful, and this sample was used to do the following 
experiments.  
2.3.1.2 Effect of knock down on SGIV infectivity 
To evaluate the effects on the SGIV resulted from asMO75 knockdown, equal 
numbers of asMO75-transfected GEC, the control transfected GEC and the 
mock transfected GEC were infected with SGIV at the same dose, and 
collected at the same time point. And TCID50 assay was performed. The 





Figure 2.2 Reduction of SGIV infectivity in asMO
75
 transected cells 




 and mock transfection were 
infected with SGIV (MOI=1) at 24h post-transfection. Samples were collected 





The data showed that the average titer of the asMO75 knockdown group 
(10^3.79) was 100 fold lower than the control group (10^5.26), while there 
was no significant difference between the control and mock group (10^5.02). 
The same infectivity of mock and control group validated the credibility of 
this experiment. The statistic result demonstrated that suppressing the 
ORF075R’s expression would result in a significant reduction of virus 
infectivity.  
The works presented above confirmed that ORF075R plays an important role 
in virus infectivity and amplification. Lack of ORF075R could reduce virus 
infectivity.  
2.3.1.3 Effect of knockdown on virus phenotype 
To further study the effect of lack of ORF075R protein, the infected GE cells 
were observed under the transmission electron microscopy (TEM). Normal 
infected GE cells and ORF075R knockdown infected GE cells were harvested 











Figure 2.3 Knockdown on virus phenotype under EM 




 were infected with SGIV (MOI=1) 
at 24h post-transfection. Samples were collected at 48h p.i. and subjected to 
EM observation. The white arrow indicated the low density area. 
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As can be seen, the normal mature SGIV capsid appeared as hexagonal under 
the TEM, and with a high density region which contained the DNA core inside. 
However, compared to the normal virus particles, many of the knockdown 
virus particles showed a portion of low density area (showed by arrow in 
Figure 2.3). Moreover, the capsid shape was not as clear a hexagonal as the 
normal one. These results showed that the virus DNA was not fully assembled 
in knockdown ORF075R virus particle, and knockdown ORF75 has effect on 
viral genome packaging. 
Similar SGIV infectivity and virus phenotype results can also be found in 
ORF018R knockdown, another structural protein from a previous study (Wang, 
et al., 2008). Both of these 2 proteins are the major capsid proteins in SGIV, it 
is possible that they have similar functions or they collaborated in virus 
assembly. Due to this hypothesis, the following experiments were performed. 
2.3.1.4 Dual knock down experiment 










were infected with SGIV at MOI of 1 at 24h post-transfection. Same methods 
were used as described in earlier section 2.3.1.1. The western blot result was 





Figure 2.4 Dual knockdown effects checked by Western blot assay 










were infected with SGIV (MOI=1) at 24h post-transfection. Total cell lysates 





From Figure 2.4, compared to the control knockdown, both ORF018R and 
ORF075R proteins expression levels were decreased by transfecting specific 
single asMO in infected GEC. In dual knockdown situation, these two protein 
expression levels were further reduced than the single knockdown. These 
results were consistent with the TEM study, more defective viral particles 
were observed in dual knockdown situation, and the unpackaged region (low 
density part) was larger than the single knockdown conditions (Tran, et al., 
unpublished data).  
One more interesting discovery of this study is that the ORF018R’s expression 
level even increased after knockdown of ORF075R. It is possible that 
ORF018R may rescue ORF075R function in knockdown ORF075R by asMO 
transfection. Although both of these two proteins are the abundant proteins in 
mature SGIV virion, ORF075R expression level is even higher than ORF018R. 
However from the TEM results, the morphology changes of the mature virus 
particles after knockdown of ORF075R were not as significant as knockdown 
of ORF018R (Tran, et al., unpublished data). It could be explain by 
a compensatory increase of ORF018R expression. In summary, the expression 
and function of ORF075R and ORF018R are closely related. Both of these 
proteins should play a critical role in SGIV genome package. They may also 
collaborate and function in other biological processes.   
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2.3.2 Subcellular localization of ORF075R  
Study of the subcellular localization of the target protein may give us some 
clues to further investigate their function. In this section, two different 
approaches were performed to study the subcellular localization of ORF075R. 
2.3.2.1 Subcellular localization study by transfection 
The first method to study the subcellular localization of the target protein was 
the expression of the protein in an exogenous plasmid. Fluorescent protein 
(EGFP) was co-expressed with ORF075R in host cells by transfection.  
Vectors pcDNA3.3 containing EGFP fusion ORF075R (at N-terminal of EGFP) 
was delivered into GEC. The transfected cells were observed under a Zeiss 
confocal microscope 30hrs post- transfection. Hoechst was used to represent 





Figure 2.5 Expression of EGFP fusion ORF075R protein in GE cells 
PcDNA3.3 containing EGFP fusion ORF075R (at N-terminal of EGFP) was 
delivered into GEC, and the transfected cells were observed under a Zeiss 
confocal microscope 30hrs post- transfection. The target protein was 
represented in green, and the dsDNA was represented in blue. 
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As shown in Figure 2.5, ORF075R was overexpressed in GE cells successfully 
(bottom line, green color). The dsDNA in host cells (nuclei) was shown in 
blue color by Hoechst.  
Compared to control cells, this figure indicated that ORF075R was 
preferentially localized in cytoplasm of the host cells. 
2.3.2.2 Subcellular localization study by immunofluorescence (IF) 
To further study the ORF075R protein localization, another methods, 
immunofluorescence (IF) was used. The infected GE cells were detected by IF 




Control GE cells 
 
Infected GE cells 
 
Figure 2.6 infected and control GE cells by immunofluorescence 
GE cells were cultured and infected with SGIV with an MOI of 1. Cells were 
fixed at 36 h p.i., and then incubated with anti-ORF075R antibody (1:500) and 
anti-rabbit AlexaFluor488-conjugated antibody for 1 hr separately. DsDNA 
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were stained with Hoechst (Invitrogen). The target protein was represented in 





As can be seen, dsDNA was shown in blue color, the larger blue spots 
represented the GEC nuclei, and the smaller spots represented the virus 
assembly centre. Actin was shown in red color, and ORF075R was showed in 
green color. In the merging figure, the green spots were especially co-localized 
with the small blue spots. 
These results showed that in the infected host cells the majority of ORF075R 
were localized in cytoplasm and accumulated in a special area. This area was 
co-localized with Hoechst, a fluorescent dye for dsDNA which illumined that 
abounds dsDNA were accumulated in this special region. SGIV is a dsDNA 
virus, so we can confirm that this ORF075R-rich area is the assembling site of 
SGIV which means our target protein should be involved in SGIV assembly. 
Moreover, the actin cytoskeletal structure was also destroyed after the virus 
infection. 
The exogenous plasmid transfection and SGIV infected host cells showed 
similar cytoplasm localization of ORF075R. In the infected host cells 
ORF075R protein performed more specialized localization in virus assembling 
site it may due to the interaction of ORF075R with other assembly vial 
proteins.  
2.4 Discussion 
The current data give us clear information that ORF075R is a key element in 
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SGIV replication cycle. First of all, knockdown of ORF075R can cause 
significant reduction of virus infectivity. Moreover, from the TEM results the 
virus DNA was not fully assembled in many knockdown ORF075R mature 
virus particle. These results illuminated that the high abundant protein ORF75 
has effect on viral genome packaging and virus infection.  
Secondly, ORF075R and ORF018R are closely related. As the two major 
structural proteins in SGIV, knockdown of either of these proteins can cause 
the occurrence of unpackaged region (low density region) in mature viral 
particles. And these defective viral particles were increased when both of these 
two proteins were knockdown by asMO. Only knockdown of ORF075R can 
stimulate a compensatory increase of ORF018R expression, while only 
ORF018R knockdown can induce hyperphosphorylation of ORF075R. These 
experiments confirmed the strong relationship between these two abundant 
proteins, both of these proteins should play a critical role in SGIV genome 
packaging. They may also cooperate and function in other biological 
processes. 
Thirdly, the sub cellular localization of ORF075R has been identified by 
different approaches. These results showed that in the infected host cells the 
majority of ORF075R were localized in cytoplasm and accumulated in a 
special area which is the virus assembling site. Previous study showed the 
specific lipid binding ability of this protein and combined with the new data 
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illuminated that ORF075R may contribute to SGIV assembly. 
In summary, ORF075R as an abundant structural protein in SGIV, was 
involved in virus genome packaging and viral particle assembly. ORF018R 
should be one of the binding partners. They perform similar functions by 
cooperation in the cytoplasm of the host cells. To further study the function of 
ORF075R, we try to analysis the sequence of this protein by the advanced 














3.1 Introduction  
In order to further investigate the function of ORF075R, proteomics 
techniques were used. Previous work from the analysis of the lysate of 
infected cells showed that ORF075R has four distinguishable spots in the 2DE 
gel. This would suggest that these different protein isoforms may have distinct 
functions in virus infection and proliferation. The distinct isoforms of 
ORF075R also suggested that this protein may undergo some post 
translational modifications.  
Post translational modification (PTM) is the chemical modification of a 
protein after its translation. Numerous biochemical functional groups may 
attach to the protein after its translation. These modifications of amino acids 
can extend the range of protein functions. In other cases, some specific amino 
acids or peptides maybe removed from the original amino acids chains. These 
sequences and structural modifications can also change the proteins function. 
To identify the different protein isoforms in greater detail, the ORF075R 
expression profile in mature virus was further analyzed. 
3.2 Materials and methods 
3.2.1 2-D Gel Electrophoresis 
The sample cells were collected, pelleted, and resuspended in lysis buffer (7M 
urea, 2M thiourea, 30mM Tris-Base, 4% CHAPS) which was premixed with 
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Halt protease inhibitor mixture (EDTA-free) and endonuclease (Sigma). 
Sample mixture was vortexed and incubated for 30 min at room temperature 
followed by centrifugation at 18000 g at 16°C for 30 min. The supernatant was 
purified by 2-DE clean up kit (Amersham) and quantified with Coomassie 
Protein Assay kit (Pierce) using BSA as the standard. After that, the samples 
were aliquoted and store in -80 ℃ or to perform the 2D electrophoresis (Bi et 
al., 2006).  
Each IPG strip containing 150 µg protein samples (18 cm pH 3–10 or pH 4–7; 
Bio-rad) was actively rehydrated for 15 h in IEF (isoelectric focusing) buffer 
(7M urea, 2M thiourea, 4% CHAPS, 20mM DTT, 0.5% IPG buffer pH 4-7), 
and was focused into a Protean IEF Cell (Bio-Rad) at 20 ℃ with the following 
successive steps: a linear increase from 0 to 1000 V for 2 hrs, a gradient phase 
from 1000 V to 10,000 V for 3 hrs, and then a hold at 10,000 V for a total of 
40 kVh. 
After first dimension focusing, the strip was incubated in Equilibration buffer 
(6 M urea, 0.375 M Tris-HCl, pH 8.8, 2 %SDS, 20 % glycerol) premixed with 
2% DTT following by 2.5% iodoacetamide for 10 min each, and performed 
second dimension SDS gel (12 % w/v SDS-PAGE).  
3.2.2 Silver staining  
Vorm method was followed to stain the SDS-PAGE gel. The gel was fixed in 
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fixative buffer (50% methanol, 12% acetic acid, 0.05% formalin) for 2 hrs, 
washed with 35 % ethanol for 3x 20 min. The gel was incubated in a sensitizer 
buffer (0.02 % Na2S2O3), rinsed with ddH2O 3X 5 min and impregnated in 
silver nitrate reagent (0.2 % nitrate, 0.02 % formaldehyde 37 %) for 20 min. 
After washing 2 X 1 min ddH2O, the gel was incubated in the developer buffer 
(6 % Na2CO3, 0.0004 % Na2S2CO3, 0.05 % formaldehyde 37 % ) for 10-20 
min, then the reaction was terminated by stop solution with 1.4%EDTA-Na2 
for 5 min, rinsed with ddH2O 3X 5 min prior to results analysis. 
3.2.3 Trypsin digestion an LC-MS/MS analysis 
Spots of interest were excised from Coomassie blue or silver staining gel and 
digested with sequencing grade modified porcine trypsin (Promega). MS and 
MS/MS spectra were obtained using the AB SCIEX TripleTOF® 5600 mass 
spectrometer (Applied Biosystems). The MS together with MS/MS spectra 
were searched against the whole NCBI database using MASCOT 2.0 (Matrix 
Science). Some post translational modification like phosphorylation also can 
be detected. 
3.3 Results 
3.3.1 Different expression profiles of ORF075R in SGIV-infected cells and 
mature virus 
The infected cell lysate and purified virus were the two types of samples 
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which were used in this experiment. Both of these two samples were collected 
at 72hrs p.i. To purify the virus, sucrose gradient centrifuge was used. Two 
samples were resuspended in lysis buffer, for each gel 150ug protein sample 
were loaded.   
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Figure 3.1 Different expression profiles of ORF075R in SGIV infected cells 
and mature virus.  
A)Purified SGIV particle lysate; B) SGIV infected GEC lysate 





Comparing the two pictures (shown in Figure 3.1), ORF075R has four spots in 
both gels, however, the profiles show a slightly different patterns between the 
two different samples. The major spot in mature virus was the one with the 
highest pI and the smallest MW (spot No.4), while the major spot in infected 
cells showed the opposite result (spot No.1). The various amount of target 
protein indicated that ORF075R may perform different functions in infected 
host cell and mature virus. 
3.3.2 Post-translational modification of ORF075R 
The detection of these four spots of ORF075R suggested that this protein 
undergoes some specific post-translational modifications in host cells. 
Analysis of ORF075R’s sequence showed that it has more than 20 potential 
phosphorylation sites (6 serine residues, 9 threonine residues and 8 tyrosine 
residues). 
Calf intestinal alkaline phosphatase (CIAP) was used to treat the infected GE 




   
A) Control 
  
B) Dephosphorylation treatment 
Figure 3.2 2DE maps of SIGV infected cells before and after 
dephosphorylation treatment 




Figure 3.2 clearly showed that after CIAP treatment, the four spots became 
one big spot which had the smallest MW and highest pI (spot No. 4). It further 
confirmed that the post-translational modification of ORF075R was due to 
phosphorylation. And the multiple potential phosphorylation sites can 
reasonably explain there are four distinguished spots in 2DE gel.  
To further confirm the PTM in ORF075R, spots in Figure 3.2 were cut and 
analyzed by mass spectrometry. The results shown in Figure 3.3 revealed that 
there were 4 amino acids residues in spot 1 been phosphorylated while only 1 










Fragment sequence Modification MW z MW/z 
ENLSAIPLHER  1277.67 2 639.84 
Phospho(S)@4 1357.62 2 679.83 
ILAHGELLPNER  1360.74 2 681.37 
Phospho(H)@4 1440.7 2 721.37 
ALDSALRSEFR  1263.65 2 632.83 
Phospho(S)@4 1343.61 2 672.82 
GKVTVPYAAYNLLR  1563.84 2 782.94 






Spot 1 identified spectrum: 
ENLSpAIPLHER 
 
Modification: phosphorylation at S residue  
ILAHpGELLPNER 
 










Modification: phosphorylation at T residue  
Figure 3.3 Identification of phosphorylated peptide of ORF075R 
The 2D picture of ORF075R spots was amplified (A). The identified peptides 
(underline block) and the phosphorylated amino acid (p) from each spot (B). 





In Figure 3.3, the fragments sequences which have been phosphorylated were 
highlighted in block. And the match mass spectrums were circled in red. The 
confidences of above results were more than 95 %. 
As one of the most important PTMs, phosphorylation usually results in a 
functional change of the target protein (substrate) by changing enzyme activity, 
cellular location, or association with other proteins protein. Previous data 
showed that knockdown ORF018R involved in ORF075R phosphorylation, 
and ORF075R showed specific binding to particular phospholipids (Wang et 
al., 2008; Wu et al., 2010). From these data, we suggested that the 
phosphorylation ORF075R could be a multifunctional signal transduction 
protein in SGIV infected host cell. Multiple phosphorylation sites might 
correspond to different binding proteins and control more than one 
downstream signals. 
3.3.3 Dynamic change of ORF075R in SGIV-infected cells 
The different expression profiles of ORF075R in infected cells and mature 
virus let us to examine the expression profile in different infected stages. 
Infected cells were collected at different time points and analyzed using 2-DE 





Figure 3.4 Time course experiment of ORF075R expression in infected GEC 
Infected cells were collected at different time points (9 h.p.i, 16 h.p.i, 20 h.p.i, 




The above figures showed the modification of ORF075R changed in the 
course of infection. The ORF075R was circled in each figure. As can be seen, 
the phosphorylation of ORF075R in infected GEC was a continuous process. 
In the early stage of infection, we can only observe the highly phosphorylated 
spots, while over time, the lower phosphorylated spots showed up in series. 
The process reveals that ORF075R expression is undergoing a dynamic 
change in infected GEC. 
3.4 Discussion 
In this experiment, three different types of phosphorylation have been found: 
serine residue phosphorylation, which was the most common type; threonine 
residue phosphorylation, the secondary common type; and histidine residue 
phosphorylation which was not as common. All of these three types of 
phosphorylation depend on special types of protein kinases, which can modify 
other proteins by chemically adding phosphate groups to them. Kinases are 
known to regulate the majority of cellular pathways, especially those involved 
in signal transduction. 
A serine/threonine protein kinase (STK) is a kinase enzyme that 
phosphorylates the OH group of serine or threonine (which have similar 
sidechains). In eukaryocyte, STK receptors play a role in the regulation of cell 




Histidine Kinases (HK) are multifunctional, typically transmembrane, proteins 
of the transferase class that play a role in signal transduction across the 
cellular membrane (Wolanin PW, et al., 2002). The HK can transfer a 
phosphate group from ATP to a histidine residue.  
As one of the most important PTMs’, phosphorylation, are part of the common 
mechanisms for controlling the behavior of a protein, activating or inactivating 
an enzyme. The complex post-translational modification reveals that 
ORF075R may interact with more than one protein in different virus infection 
stages. As a phosphate receptor, different protein kinases (STK and HK should 
be the two major types protein kinases) modified ORF075R, and through this 
biological process, switched on the downstream signal pathways.  
It is not surprising that phosphorylation occurs on multiple distinct sites on a 
given protein. Duck hepatitis B virus (DHBV) is a small enveloped virus with 
a partially double-stranded circular DNA genome. The capsid protein of 
DHBV contents three serines and one threonine in the C-terminal 24 amino 
acids as phosphorylation sites. These residues affects distinct steps in viral 
replication which including DNA synthesis within viral nucleocapsids, 
covalently closed circular DNA synthesis and virus production, and the 
initiation of infection, respectively (Yu and Summers, 1994).  We can also 
find similar example form RNA virus, Hepatitis C virus (HCV) is an 
enveloped, positive sense, single-stranded RNA viruses. The NS5A protein of 
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HCV contains multiple phophorylation residues which is essential for RNA 
replication and virion assembly. The phosphorylation of NS5A can negatively 
regulate virus RNA replication (Lemay et al., 2012). The results implied that 
both phosphorylated and nonphosphorylated proteins were necessary for viral 
particle to carry out all its functions in virus replication. It might explain that 
in infected cell lysate more ORF075R were phosphorylated than in purified 
mature virus. And also consistent with the result that ORF075R was highly 
phosphorylated in early infection stage. The phosphorylation of ORF075R 
may be a reversible reaction, because the phosphorylation modification also 
can detect even in the highest pI isoform. 
The study of expression profiles and post translational modification of 
ORF075R gave us many useful clues to further investigate ORF075R host 
protein interaction. In future experiment, STK and HK should be the good 
candidates of ORF075R binding partners. And directed mutagenesis may be a 
good method in further study, as the phosphorylated residues were already 
recognized, we can replace these residues by other amino acids (alanine for 
example). To observe the defect of the mutagenesis protein could help us 










iTRAQ Study of the Host and Viral Proteins of Non-infected and Infected 





In our previous study of SGIV, we have carried out comprehensive researches 
on the viral genome (Song et al. 2004), transcriptome (Chen et al. 2006), 
proteome (Song et al. 2005, Chen et al. 2008) and lipidome (Wu et al. 2010). 
However, these researches were focused on SGIV per se. Researches on the 
hosts (grouper fish) and host cells, are constrained due to unknown host 
genome sequences and limited biological information. We only identified a 
limited number of host cellular proteins in SGIV-infected grouper embryonic 
cells, and majority of those identified proteins are highly conserved (Chen et 
al. 2008).  
Here, we firstly established a successful infection protocol using newly 
developed embryonic cell line from zebrafish. We further knocked down the 
viral genes from three different classes, namely viral immediate early gene 
(ORF086), early gene (ORF158) and late genes (ORF018 and ORF075, 
encoding major viral structural proteins) via antisense morpholinos. Protein 
samples from the SGIV-infected zebra fish cells with or without antisense 
morpholino treatment were then analyzed in parallel using iTRAQ method. 
This analysis revealed a numerous cellular proteins, and could significantly 





4.2.1 Cell line and virus infection 
To identify more host proteins which were regulated during the SGIV 
infection, zebrafish embryo cell line was used as the host cell in this study, and 
it was cultured under the following protocol (Li Zhendong phD thesis, 
Department of Biological Science, NUS) 
4.2.1.1 Preparation of medaka embryo extract 
Medaka (Oryzias latipes) embryos were collected, and separated by rolling 
with two needles, then incubated at 26°C in a 10 cm bacterial logical petri dish 
with embryo rearing medium (ERM) (KCl 0.03 g, NaCl 1.00 g, MgSO4·7H2O 
0.16 g, CaCl2 ·2H2O 0.04 g, Methylene blue 0.01 mg, final volume 1000 ml). 
Culture medium was replaced every day, and dead embryos stained with blue 
color were removed to prevent mold contamination. After seven days of 
culture, embryos were collected, drained and stored at -20°C for subsequent 
process. For every 10,000 embryos, they were thawed and homogenized on ice. 
The homogenates were diluted with PBS to a final concentration around 400 
embryos per ml. The mixture then was fast frozen and thawed three times with 
liquid nitrogen following spun at 18,000 rpm at 4°C for 30 min. The upper 
lipid phase was removed and the remaining components were centrifuged 
again until lipid phase was invisible. The clear supernatant was transferred to 
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EP tubes and aliquot stored at -20°C. 
4.2.1.2 Preparation of fish serum 
Fish serum has mitogenic roles in culturing fish ES cells. Fish serum from 
rainbow trout (Oncorhynchus mykiss), common carp (Cyprinus carpio) and 
seabass (Lates calcarifer) has been used. Fish blood was collected from tail 
vein by a 10-ml syringe with trace of anti-coagulation (heparin or EDTA) and 
spun at 4°C for 30 min at 4,000 rpm. Then the upper clear supernatant was 
stored at -20°C in 1 ml aliquot until used. 
4.2.1.3 ESM4 medium Preparation  
The embryonic stem cell medium 4 (ESM4) was used culture zebrafish cell 
line. It consists of DMEM 13.4 g/l (Gibico), 20 mM Hepes (sigma), 15% FBS 
(Gibico), 1×penicillin and streptomycin (Invitrogen), 2 nM L- glutamine 
(Invitrogen), 1x Non-essential amino acids (Invitrogen), 1× Na pyruvate 
(Invitrogen), 100 μM 2-mercaptoethanol (Sigma), 2 nM Na selenite (Sigma), 
0.2% seabass serum, 10 ng/ml bFGF, 0.4 embryo/ml medaka embryo extract 
(MEE), final pH 7.5. 
4.2.1.4. Preparation of tissue culture plate 
Culture dish or plates were pre-coated with gelatin (Sigma). Briefly, 0.1% 
gelatin solution was autoclaved, filtrated through 0.22 um filter, added into the 
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dishes or plates and incubated at room temperature for 1 h. Then the gelatin 
solution was aspirated followed by air-drying for at least 2 hours. 
4.2.1.5 Subculture of zebrafish cells 
Zebrafish cells (established in Prof. YH. Hong’s lab at NUS) grown in 
pre-coated plate or petri dish were rinsed three times with PBS to remove the 
residual medium and incubated with 1×Trypsin-EDTA (Invitrogen) for 3-5 
minutes. Then Trypsin-EDTA solution was aspirated and fresh ESM4 medium 
was added. The cells were re-suspended by pipetting up and down several 
times and split by 1:3 to other plates or dishes. 
4.2.1.6 Counting Cells 
Cell suspension was prepared by trypsination and dropped into the chamber of 
the hemacytometer (Sigma). Cell counting was done according to the 
instructions. 
4.2.1.7 Cells transfection and virus infection 
The asMOs design and transfection has been described in Chapter 2 (section 
2.2.2). Four viral genes from different classes, have been selected and 




Table 4.1 Designed asMOs 
Knockdo
wn target 





Knockdown target Synthesized asMO Target location 
Control CCTCTTACCTCAGTTACAATTTATA  
ORF018R GCGTTCAGATAGTTTTACGGACATC -1-- +24 
ORF075R CTCCGAAAATATCGTCGATATCCAT 0--+25 
 
Control CCTCTTACCTCAGTTACAATTTATA   
ORF086 CATGGTGTTTGGTAGTGTTT -21--+3 immediate early 
ORF158 AGTTTFCTACGATGGCCCACCCAT 0--+25 early 
ORF018R GCGTTCAGATAGTTTTACGGACATC -1-- +24 late 
ORF075R CTCCGAAAATATCGTCGATATCCAT 0--+25 late 
Same protocol was preformed to transfect the asMOs to zebrafish cell line. 
Then the transfected cells were equally divided to two dishes and one of the 
cells were infected by SGIV (MOI=0.1) at 40 hrs post transfection. 
4.2.2 iTRAQ labeling and two dimensional LC-MALDI MS 
4.2.2.1 Protein extraction 
The non infected cells and infected cells (48 hours post infection of SGIV) 
were lysed with TEAB lysis buffer (0.5 M triethylammonium bicarbonate, pH 
8.5, containing 1 % SDS) incubated on ice for 30 min, heated at 60 ℃ for 
another 30 min and then spun down 14,000rpm at 4 ℃ for 1.5 hour. After 
treatment, proteins were pooled and quantified by BCA protein assay kit 
followed the manufacturer’s instructions. Equivalent amount (100 micrograms) 
of total proteins from each experiment conditions were used for iTRAQ 
experiments. 
4.2.2.2 Isobaric labeling 
The proteins were reduced and cysteines blocked according to the iTRAQ 
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kit‘s protocol (Applied Biosystems, Foster City, California, USA). Then, the 
samples were 10X diluted with 0.5 M TEAB buffer, pH 8.5, and incubated 
with 25 microliters of a 1 μg/μL trypsin (Applied Biosystems) at 37 °C 
overnight. The samples were vacuum-dried and reconstituted with 30 μL 0.5 
M TEAB buffer, pH 8.5. Then the samples were incubated with iTRAQ 
reagents respectively at RT for 1 hr. 
Two independent runs were performed, for each run 100 micrograms of 
protein from each experimental condition labeled with 8-plex iTRAQ reagents 
as showed in table 4.2 
Table 4.2 isobaric labeling 
First running: 
iTRAQ reagents Treatments 
Knockdown gene Infected or not 
113 control Non-infected 
114 infected 
115 ORF018 Non-infected 
116 infected 
117 ORF075 Non-infected 
118 infected 







iTRAQ reagents Treatments 
Knockdown gene Infected or not 
113 control Non-infected 
114 infected 
115 ORF018 Non-infected 
116 infected 
117 ORF086 Non-infected 
118 infected 
119 ORF158 Non-infected 
121 infected 
4.2.2.3 Cation exchange and desalting 
The labeled samples were pooled and resolved into 20 fractions using strong 
cation exchange (SCX) column (Applied Biosystems). The bound peptides 
were eluted with 5 % NH4OH in 30 % methanol. After drying, the eluted 
fractions were resuspended with 20 μL 5 mM KH2PO4 buffer containing 5 % 
ACN, pH 3.0, and separated using an Ultimate dualgradient LC system 
(Dionex-LC Packings). The iTRAQ-labeled peptide samples were dried and 
stored at -80 °C before MS analysis.  
4.2.2.4 LC-MS/MS analysis 
The dried iTRAQ-labeled peptide samples were dissolved in HPLC grade 
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water (J.T.Baker, Phillipsburg, New Jersey, USA) acidified with 0.1% formic 
acid, and sequentially injected and separated with LC-MS/MS system 
(Applied Biosystems). Spectra acquired in LC-MS/MS system were submitted 
in a batch to ProteinPilot (v2.0.1, Applied Biosystems) for peak-list generation, 
as well as protein identification and quantification against the Sanger Institute 
zebrafish genome Zv9 (released on Nov 10th 2010) 
(http://www.sanger.ac.uk/Projects/D_rerio/) and SGIV entire genome 
supplemented with porcine trypsin. The Paragon algorithm in ProteinPilot 
software was configured as all cleavage variants were considered. 
4.2.3 Transmission electron microscope 
This has been described in Chapter 2 (Section 2.2.7) 
4.2.4 TCID50 test 
This has been described in Chapter 2 (Section 2.2.6) 
4.2.5 Western blot assay 
This has been described in Chapter 2 (Section 2.2.5) 
4.3 Result  
4.3.1 Demonstration of SGIV Replication in Zebrafish Cell Line 
To investigate the infectivity of SGIV in zebrafish cells, and to compare the 




4.3.1.1 Microscopical observation infected ZC  
To investigate the phenomena of SGIV infected zebrafish cell line, the ZC 
were infected by SGIV (MOI=0.1). The photos were taken at 24hrs p.i., and 
the non-infected ZC were displayed as a control. 
From Figure 4.1, we can observe similar cytopathic effect (CPE) as with the 
grouper embryonic cell line infected by SGIV: cells shapes were altered, the 
membrane was fusion, and cells were detached from substrate. This is strong 






    
A)                             B) 
    
C)                              D) 
Figure 4.1 SGIV infected ZC 
A) Normal cultured zebrafish cells; B) SGIV infected zebrafish cells; C) 




4.3.1.2 ORF075R expression analysis with Western Blot assay. 
Both the GEC and ZC were infected by SGIV (MOI=1). Samples were 
collected in a serial time course (12hrs, 24hrs, 36hrs and 48hrs p.i.). The 
antibody against ORF075R was used to detect the virus protein expression in 
these two cell lines. The actin was used as an internal control. 
As shown in Figure 4.2, although the signal of virus protein from ZC was 
slightly weaker than the signal from GEC, it can still be seen that the 
ORF075R expression accumulated with the elapse of infection time, which is 








Figure 4.2 Western blot confirms the expression of ORF075R in two cell lines 
GEC and ZC were infected by SGIV (MOI=1). Samples were collected in a 
serial time course (12hrs, 24hrs, 36hrs and 48hrs p.i.). The antibody against 
ORF075R was used to detect the virus protein expression in these two cell 




4.3.1.3 Virus infectivity analysis with TCID50 assay 
To compare the infectivity of SGIV produced in GEC and ZC, equal number 
of GEC and ZC were infected with SGIV at the same dose and cells were 
collected at 48hrs p.i. TCID50 assay was performed, to examine the viral titer 
in the two samples. 
The TCID50 result was quite consistent with the western blot data. The viral 
titer in the sample from ZC showed a lower infectivity than the virus titer from 
the GEC. This can be explained as ZC was not the original host of SGIV in 








Figure 4.3 SGIV infectivity produced by different cell lines 
The GEC and ZC were infected with SGIV (MOI=1) at 24h post-transfection. 
Samples were collected at 48h p.i. The variation of the virus infection 






                
Purified SGIV from ZC            B) Purified SGIV from GEC 
Figure 4.4 Purified SGIV from two cell lines 
The GEC and ZC were infected with SGIV (MOI=1) at 24h post-transfection. 




4.3.1.4 Observation of SGIV particle under electron microscope  
The ZC was infected by SGIV, cells were collected 72hrs p.i., and virus 
particle was purified by sucrose gradient centrifuge.  
From the EM picture, we can see that the SGIV particle isolated from ZC 
possesses the similar morphology as it does in GEC. This is a direct evidence 
supporting that SGIV can amplify in ZC. 
4.3.1.5 Summary of SGIV infectivity in ZC 
To summarize all the data presented above, we showed that ZC can be infected 
by SGIV successfully, and can produce mature SGIV particles. It is the first 
report of infected zebrafish cell by iridovirus. These results demonstrate that 
the zebrafish can be considered as an appropriate model in virus infection 
research. In the following experiments, we used the ZC as a host cell line to 
investigate the virus-host interaction of SGIV. Meanwhile, this section of work 
also illuminated the possibility of SGIV infecting a wider host species.  
4.3.2 Identification of differentially expressed host proteins 
To investigate the global proteomic alteration in infected knockdown zebrafish 
cells, the iTRAQ analyses were performed.  
4.3.2.1 iTRAQ Proteomics Profiling of Zebrafish Cell Lines 
A strict cutoff for unused (peptides not claimed by another protein) protein 
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score≥ 1.3 was used as the first qualification criterion which corresponds to a 
5% false discovery rate. In the first run, there were 2284 host proteins found, 
in which 668 proteins were identified with total ion score C.I % ≥ 95 %. 313 
of them have been found in all 8 plex. In the second run, there were 3473 host 
proteins found, in which 2122 proteins were identified with total ion score C.I % 
≥ 95 %. 1495 of them have been found in all 8 plex. In total, 461 proteins were 
found in both runs with unused protein score ≥ 1.3. 
The identified host proteins can be localized by using STRAP analysis 
(Software Tool for Rapid Annotation of Proteins). In both of the two results, 
cytoplasmic proteins (16 % in 1
st
 run and 18 % in 2
nd
 run), nuclear proteins 
(13 % in 1
st
 run and 21 % in 2
nd
 run), chromosome proteins (13 % in 1
st
 run 
and 6 % in 2
nd
 run) and molecular complex (10 % in 1
st
 run and 9 % in 2
nd
 run) 
are the four most abundant types. Meanwhile, there are also approximating 
one fifth of the total proteins (20 % in 1
st
 run and 17 % in 2
nd
 run) remained 
unclassified in these experiments (Figure 3.5)  
Compared to the previous study in iTRAQ analysis of SGIV (Chen et al., 
2008), more host proteins have been found in our results (2284/3473 VS 726), 
it may due to the availability of the completely sequenced zebrafish genome. 






Figure 4.5 Cellular distribution of all the proteins identified in two separate 
iTRAQ running experiments. 
The identified host proteins were localized by using STRAP analysis 
















1st Run Cellular Component 
Cytoplasm 
Macromolecular complex 

























2nd run Cellular Component 
Cytoplasm 
Macromolecular complex 














3.3.2.2 Gene Ontology Study of the iTRAQ identified proteins 
Same batches of proteins discussed in the last section have been classified by 
their molecular function. The results were showed in Figure 3.6. Enzyme 
activity (45 % in both run) and binding (34 % in 1
st
 run and 35 % in 2
nd
 run) 
are the two major types of proteins found by these experiments.  
Compared to previous study (Chen et al., 2008), we clearly classified the 
protein candidates by their molecular function by using STRAP analysis. 








Figure 4.6. Classification of identified proteins by their molecular functions 
using STRAP 
The identified host proteins were localized by using STRAP analysis 






































3.3.2.3 Significantly Altered Proteins 
To further investigate the host protein altered after different treatments. A strict 
cutoff for iTRAQ radio change ≥ 1.5 fold was used to select the protein 
candidates. The numbers of up- or down-regulated (radio ≥ 1.5000 or ≤0.6666) 
proteins between infected or non-infected zebrafish cells were showed in 
Table 4.3. 














50 18 74 22 
KD ORF086 
(118:117) 
N/A 21 N/A 40 
KD ORF158 
(121:119) 
43 33 70 148 
KD ORF18 
(116:115) 
34 47 35 30 
KD ORF75 
(118:117) 
59 N/A 54 N/A 
The proteins which were significant altered (more than 1.5 fold) after SGIV 



















1 54.61 63.29  IPI00511483 eef2b Eukaryotic translation elongation factor 2, like 0.145881 
2 23.69 85.11  IPI00972490 - 34 kDa protein 0.169044 
3 74 76.92  IPI00486027 krt8 Keratin, type II cytoskeletal 8 0.180302 
4 78.49 88.97  IPI00897805 zgc:111961 ATP synthase subunit beta 0.192309 
5 6.92 48.76  IPI00555419 zgc:110343 Zgc:110343 protein 0.255859 
6 7.19 50.19  IPI00486242 
si:ch211-146f4.5 Novel protein similar to human and rodent procollagen-proline, 
2-oxoglutarate 4-dioxygenase (Proline 4-hydroxylase), alpha polypeptide I 
0.265461 
7 35.83 60.75  IPI00932464 LOC795591 hypothetical protein isoform 1 0.275423 
8 55.15 61.38  IPI00505750 hspa5 Immunoglobulin binding protein 0.280543 
9 2.11 44.29  IPI00481155 rpl23 60S ribosomal protein L23 0.291072 
10 20.95 55.38  IPI00491587 pgd 6-phosphogluconate dehydrogenase, decarboxylating 0.299226 
11 14.53 44.53  IPI00488483 tdh Novel protein 0.30479 
12 15.94 59.47  IPI00503124 tuba8l Tubulin, alpha 8 like 0.319154 
13 2 26.85  IPI00899114 si:ch211-262e15.1 forkhead box K2 isoform 2 0.3191538 
14 10.1 33.27  IPI00490140 nat10 N-acetyltransferase 10 0.322107 
15 6.87 58.60  IPI00510559 rpl10 Ribosomal protein L10 0.325087 
16 12 30.14  IPI00503297 fkbp9 Novel protein 0.337287 
17 17.66 39.13  IPI00507875 psmd2 Proteasome (Prosome, macropain) 26S subunit, non-ATPase, 2 0.349945 
18 3.4 15.44  IPI00861743 - 143 kDa protein 0.353183 
19 9.2 33.79  IPI00897502 





20 10 27.80  IPI00506979 zgc:110815 Zgc:110815 0.3837073 
21 10.05 36.17  IPI00801488 zgc:158138 Zgc:158138 protein 0.394457 
22 21.23 61.06  IPI00832173 sptbn1 spectrin, beta, non-erythrocytic 1 0.398107 
23 4.14 43.49  IPI00512644 hnrnph1l Zgc:85960 0.401791 
24 6.3 39.29  IPI00861611 arpc4;arpc4l Arpc4l protein 0.413047 
25 2 25.68  IPI00503715 akt2 V-akt murine thymoma viral oncogene homolog 2 0.416869 
26 6.08 46.67  IPI00487033 
ywhae2 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, epsilon polypeptide 2 
0.42462 
27 6 25.37  IPI00513225 si:ch211-12e1.4 Si:ch211-12e1.4 protein 0.436516 
28 12.21 36.20  IPI00495614 taldo1 Transaldolase 0.452898 
29 8.03 33.57  IPI00487186 tars Novel prtoein similar to vertebrate threonyl-tRNA synthetase 0.452898 
30 28.64 47.06  IPI00508338 actn4 Actn4 0.465586 
31 5.33 35.41  IPI00482450 
p4ha2 Procollagen-proline, 2-oxoglutarate 4-dioxygenase (Proline 4-hydroxylase), 
alpha polypeptide 2 
0.465586 
32 1.54 23.30  IPI00513520 rfx2 DNA-binding protein RFX2 0.465586 
33 32.05 72.08  IPI00497676 vdac2 Voltage-dependent anion channel 2 0.474242 
34 16.76 38.38  IPI00486574 hdlbp High density lipoprotein-binding protein 0.47863 
35 6.54 63.41  IPI00962672 zgc:86841 Zgc:86841 0.487529 
36 16.15 38.25  IPI00932462 zgc:92480 78 kDa protein 0.49204 
37 4 39.62  IPI00495827 calrl2;LOC100331603 Calreticulin, like 2 0.4920395 
38 5.25 17.54  IPI00933140 plxnb2a Plexin B2 0.5011872 
39 6.62 30.80  IPI00614245 naa15a NMDA receptor-regulated gene 1a 0.515229 
40 4 18.85  IPI00483143 hm13 Signal peptide peptidase 0.519996 
41 2 12.14  IPI00494963 ptcd3 Pentatricopeptide repeat-containing protein 3, mitochondrial 0.5248075 
42 14.04 62.92  IPI00493342 hibadhb 3-hydroxyisobutyrate dehydrogenase b 0.529663 
43 6.92 32.78  IPI00509630 psmc4 proteasome 26S subunit, ATPase, 4 0.529663 
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44 2.01 44.68  IPI00508736 leo1 RNA polymerase-associated protein LEO1 0.534564 
45 4 34.81  IPI00931145 LOC572231 hypothetical LOC572231 0.5345644 
46 7.52 32.73  IPI00512269 ldha L-lactate dehydrogenase A chain 0.539511 
47 2.27 37.58  IPI00480881 pgp phosphoglycolate phosphatase 0.539511 
48 23.78 28.59  IPI00817540 zgc:152896 Zgc:152896 0.544503 
49 16.65 44.80  IPI00920207 gmps Guanine monphosphate synthetase 0.544503 
50 10.7 41.30  IPI00898337 LOC100148915 glucose-6-phosphate dehydrogenase-like 0.549541 
51 6.72 21.82  IPI00492652 LOC554685;LOC100151449;heatr1 HEAT repeat-containing protein 1 0.549541 
52 1.5 17.43  IPI00806642 lrrn1 Lrrn1 protein 0.549541 
53 47.01 36.78  IPI00898876 flna filamin A, alpha 0.554626 
54 6.03 20.81  IPI00496921 
ppm1g Protein phosphatase 1G (Formerly 2C), magnesium-dependent, gamma 
isoform 
0.5546257 
55 10.52 35.03  IPI00491239 npepps aminopeptidase puromycin sensitive 0.570164 
56 7.6 18.95  IPI00931798 - 275 kDa protein 0.5701643 
57 21.33 39.90  IPI00483652 aco2 Aconitase 2, mitochondrial 0.57544 
58 42.6 65.40  IPI00506427 lmna Lamin A 0.580764 
59 6.22 28.31  IPI00829298 pds5a Sister chromatid cohesion protein PDS5 homolog A 0.580764 
60 20.13 41.11  IPI00509057 copa Coatomer protein complex subunit alpha 0.586138 
61 4.01 58.25  IPI00639693 ddx3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 0.586138 
62 4 36.90  IPI00510683 psma6l Proteasome subunit alpha type 0.5861382 
63 14.15 56.68  IPI00512109 anxa2a Annexin A2a 0.591562 
64 4 19.39  IPI00876724 zgc:171801 Zgc:171801 protein 0.597035 
65 8.03 27.73  IPI00491150 eif3m Eukaryotic translation initiation factor 3 subunit M 0.6025596 
66 10.22 55.12  IPI00551909 psmb3 Proteasome subunit beta type 0.60256 
67 13.67 40.20  IPI00511624 pcca Propionyl-Coenzyme A carboxylase, alpha polypeptide 0.608135 
68 8 57.36  IPI00817619 mapre1 29 kDa protein 0.608135 
92 
 
69 2 34.88  IPI00486987 
si:dkeyp-66g8.1 Novel protein similar to vertebrate GATA zinc finger domain 
containing 2B 
0.608135 
70 8 40.92  IPI00614827 idh3g isocitrate dehydrogenase 3 (NAD+) gamma 0.613762 
71 4.01 20.91  IPI00771899 acox1 Acyl-Coenzyme A oxidase 1, palmitoyl 0.613762 
72 2.03 39.19  IPI00489451 aif1l Novel protein 0.613762 
73 11.34 30.90  IPI00509051 kars Lysyl-tRNA synthetase 0.613762 
74 19.73 38.89  IPI00772565 scinla Scinderin like a 0.619441 
75 37.67 68.34  IPI00484639 aldh1a2 Aldehyde dehydrogenase 1 family, member A2 0.625173 
76 6.82 25.88  IPI00485615 xpo1 exportin 1 0.625173 
77 3.34 53.90  IPI00482496 tuba8l2;LOC100330913 Tubulin, alpha 8 like 2 0.630957 
78 21.59 64.43  IPI00506192 ahcy Adenosylhomocysteinase 0.6309574 
79 17.73 30.92  IPI00502066 usp10 wu:fc76g05 isoform 1 0.6309574 
80 2.38 21.04  IPI00481071 zgc:65870 Zgc:65870 0.6309574 
81 8.09 55.38  IPI00505076 psma8 Proteasome subunit alpha type 0.636796 
82 8.02 26.44  IPI00491996 zc3h7b hypothetical protein 0.636796 
83 2.11 23.08  IPI00635460 zgc:153377 Zgc:153377 0.636796 
84 2.92 33.45  IPI00482860 sf3a2 Splicing factor 3a, subunit 2 0.6426877 
85 2.43 32.12  IPI00508593 ppp2r5eb Protein phosphatase 2, regulatory subunit B 0.6426877 
86 2 49.80  IPI00963392 LOC100332205 guanine nucleotide-binding protein, beta-4 subunit-like 0.6426877 
87 10.86 34.36  IPI00490214 LOC558088 Novel protein similar to vertebrate carnitine palmitoyltransferase 1A 0.642688 
88 8.23 35.48  IPI00511925 rpl3 Ribosomal protein L3 0.642688 
89 8.01 48.91  IPI00901134 si:ch211-67f24.5 lectin, galactoside-binding, soluble, 3 0.642688 
90 7.52 39.53  IPI00611974 ddx21 Ddx21 protein 0.642688 
91 8.59 47.39  IPI00511834 uchl3 Ubiquitin carboxyl-terminal esterase L3 0.6486344 
92 15.82 59.50  IPI00490850 aldocb Fructose-bisphosphate aldolase C-B 0.648634 
93 7.33 27.30  IPI00496784 txndc5 Thioredoxin domain containing 5 0.648634 
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94 4 20.62  IPI00882984 zgc:174908 Zgc:174908 protein 0.6606935 
95 3 32.86  IPI00486869 mhc1ufa Major histocompatibility complex class I UFA gene 0.6606935 
96 2.02 21.84  IPI00497252 si:ch211-59d15.5 Novel protein similar to vertebrate YLP motif containing 1 0.6606935 
97 12.03 44.71  IPI00486166 ruvbl2 RuvB-like 2 0.660694 
98 3.6 54.30  IPI00769589 LOC798846 Novel protein similar to vertebrate heat shock 70kDa protein 1B 0.660694 
99 2.74 27.13  IPI00507553 LOC100333050 Truncated Smad4 0.660694 
100 12.01 38.38  IPI00932722 stip1 62 kDa protein 0.666807 
101 2.01 63.68  IPI00617261 hspa8l Heat shock cognate 70 kDa protein 0.666807 
102 86.21 38.23  IPI00631543 dync1h1 Dynein cytoplasmic 1 heavy chain 1 1.513561 
103 8.7 66.67  IPI00504889 tbca Tubulin cofactor a 1.513561 
104 38.71 64.81  IPI00483215 eno1 Enolase 1.513561 
105 6.57 64.96  IPI00679292 zgc:123292 Zgc:123292 1.513561 
106 10.11 52.12  IPI00931220 wu:fd44a05 47 kDa protein 1.527566 
107 28.46 45.02  IPI00506057 hsp90b1 Tumor rejection antigen (Gp96) 1 1.527566 
108 52.68 55.48  IPI00865996 spna2 Alpha II-spectrin 1.5417 
109 10.19 46.50  IPI00484953 api5 Apoptosis inhibitor 5 1.5417 
110 7.52 38.82  IPI00508820 zgc:66306 Zgc:66306 1.5417 
111 8 63.53  IPI00961203 LOC100006097 transcription factor BTF3 homolog 4-like 1.5417 
112 4.01 18.44  IPI00960584 wu:fb40g11 hypothetical protein LOC322006 1.570363 
113 4 32.52  IPI00494766 rpl35 60S ribosomal protein L35 1.584893 
114 6.66 39.25  IPI00864633 zgc:92194 Zgc:92194 1.599558 
115 5.75 25.36  IPI00510677 usp14 Ubiquitin carboxyl-terminal hydrolase 1.599558 
116 5.43 30.38  IPI00504292 nsfl1c NSFL1 (P97) cofactor 1.599558 
117 2.03 22.19  IPI00482344 zgc:55741 Zgc:55741 1.599558 
118 11.7 25.18  IPI00499072 eftud2 Eftud2 protein 1.614359 
119 2.1 19.91  IPI00501731 pafah1b3 Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 1.614359 
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120 12.05 56.18  IPI00501560 g3bp1 GTPase activating protein (SH3 domain) binding protein 1 1.614359 
121 16.05 32.37  IPI00500527 farsb Phenylalanine-tRNA synthetase-like 1.6292959 
122 16.04 61.62  IPI00497720 fhla Four and a half LIM domains a 1.6292959 
123 8.01 36.46  IPI00961701 LOC100334924 neutral alpha-glucosidase AB-like 1.629296 
124 4.32 28.53  IPI00656507 ktelc1 Zgc:123318 1.629296 
125 4.01 33.42  IPI00860014 LOC100334022 mitochondrial ribosomal protein L38-like 1.629296 
126 15.97 43.36  IPI00481246 ctps CTP synthase 1.644372 
127 8 65.45  IPI00509732 rpl12 Ribosomal protein L12 1.674943 
128 5.4 35.97  IPI00758980 atp1b1a ATPase, Na+\/K+ transporting, beta 1a polypeptide 1.690441 
129 13.63 55.16  IPI00508889 etfa Electron-transfer-flavoprotein, alpha polypeptide 1.690441 
130 1.4 17.51  IPI00902221 - 283 kDa protein 1.706082 
131 15.92 32.86  IPI00495792 hk2 Hexokinase 2 1.721869 
132 57.04 78.22  IPI00492989 tuba8l4 Tubulin, alpha 8 like 4 1.721869 
133 6.02 47.26  IPI00497960 yars Tyrosyl-tRNA synthetase, cytoplasmic 1.7701091 
134 4 29.96  IPI00486724 tmem48 Nucleoporin NDC1 1.770109 
135 7.05 33.92  IPI00499030 tia1l TIA1 cytotoxic granule-associated RNA binding protein 1.819701 
136 1.4 52.87  IPI00489577 desma Desm protein 1.836538 
137 13.65 27.95  IPI00486103 cpne1 Copine III 1.870682 
138 20.61 61.43  IPI00507046 psmd3 Proteasome (Prosome, macropain) 26S subunit, non-ATPase, 3 1.887991 
139 2.36 25.24  IPI00500366 tcea1;tcea3 Transcription elongation factor A (SII), 1 1.923092 
140 33.48 85.83  IPI00497388 ckbb Creatine kinase, brain b 1.923092 
141 2.01 26.29  IPI00615721 LOC100329263 LReO_3-like 1.940886 
142 10.74 35.03  IPI00607441 ncl1 Isoform 2 of Nicalin-1 1.958845 
143 25.81 77.74  IPI00512157 zgc:64133 Malate dehydrogenase 1.995262 
144 11.89 43.80  IPI00932106 nop56 NOP56 1.995262 
145 2.61 35.89  IPI00506479 pura Purine-rich element binding protein A 1.995262 
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146 2.23 28.24  IPI00618527 ubr5 LOC571063 protein 2.013724 
147 19.17 49.93  IPI00487537 mcm7 MCM7 minichromosome maintenance deficient 7 2.0701411 
148 13.33 42.39  IPI00570064 actr2b Actin-related protein 2-B 2.128139 
149 22.31 68.46  IPI00483337 pl10 Putative RNA helicase 2.14783 
150 2.84 34.59  IPI00851590 zgc:110695 ubiquitin-like protein FUBI-like 2.1677041 
151 2.38 28.71  IPI00494756 prpf3 U4/U6-associated RNA splicing factor 2.167704 
152 52.39 36.20  IPI00972187 - 543 kDa protein 2.187762 
153 1.42 40.17  IPI00484810 rpl34 60S ribosomal protein L34 2.208005 
154 34.96 60.12  IPI00506014 hspa9 Heat shock protein 9 2.228435 
155 2 19.25  IPI00487156 capns1b Capns1b protein 2.290868 
156 16 65.69  IPI00493442 rbm4.3 hypothetical protein LOC406277 2.312065 
157 11.1 64.02  IPI00508226 ppia Peptidyl-prolyl cis-trans isomerase 2.333458 
158 5.95 31.84  IPI00899082 LOC100151500 histone cluster 1, H1b-like 2.333458 
159 3.66 23.25  IPI00611897 nsfa N-ethylmaleimide-sensitive factor 2.355049 
160 4.52 62.41  IPI00488350 cox5aa Cytochrome c oxidase subunit Vaa 2.488857 
161 10.02 67.55  IPI00494738 rps13 Ribosomal protein S13 2.606153 
162 3.5 42.10  IPI00491820 hsp90a.2 Novel protein similar to heat shock protein 90-alpha 3.34195 
163 3.28 28.87  IPI00829146 zgc:158649 Novel protein with a Glycosyl hydrolase family 85 domain 3.4994521 
164 8.99 24.76  IPI00829204 cnot1 CCR4-NOT transcription complex subunit 1 3.564511 
165 15.4 40.91  IPI00920260 ncl Zgc:152810 4.365159 
166 2.12 23.10  IPI00800843 sfxn4 Sideroflexin 4 5.395106 
167 2.07 26.67  IPI00920704 sf1 18 kDa protein 7.516229 
168 6.88 35.47  IPI00845912 zgc:123333 alpha-N-acetylgalactosaminidase 7.798301 





Additionally, the iTRAQ radios can also represent the protein expression change in 
infected host cells between control and knockdown treatment, as shown in Table 4.5. 
The Table 4.6 listed the proteins which have been significantly altered both in SGIV 
infection and after knockdown a target viral gene.  
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114:113 116:114 118:114 121:114 
1 54.61 63.29  IPI00511483 eef2b Eukaryotic translation elongation factor 2, like 0.14588 4.7863 2.51189 1.78649 
2 23.69 85.11  IPI00972490 - 34 kDa protein 0.16904 4.28548 1.34276 0.99083 
3 74 76.92  IPI00486027 krt8 Keratin, type II cytoskeletal 8 0.1803 4.44631 1.00925 0.91201 
4 78.49 88.97  IPI00897805 zgc:111961 ATP synthase subunit beta 0.19231 3.94457 0.77983 0.96383 
5 6.92 48.76  IPI00555419 zgc:110343 Zgc:110343 protein 0.25586 2.96483 0.95499 0.33729 
6 7.19 50.19  IPI00486242 
si:ch211-146f4.5 Novel protein similar to human and 
rodent procollagen-proline, 2-oxoglutarate 
4-dioxygenase (Proline 4-hydroxylase), alpha 
polypeptide I 
0.26546 3.34195 1.35519 1.87068 
7 35.83 60.75  IPI00932464 LOC795591 hypothetical protein isoform 1 0.27542 3.90841 1.19124 3.13329 
8 55.15 61.38  IPI00505750 hspa5 Immunoglobulin binding protein 0.28054 2.75423 0.83176 1.51356 
9 2.11 44.29  IPI00481155 rpl23 60S ribosomal protein L23 0.29107 3.98107 2.14783 2.70396 
10 20.95 55.38  IPI00491587 
pgd 6-phosphogluconate dehydrogenase, 
decarboxylating 
0.29923 2.80543 0.58614 0.06427 
11 14.53 44.53  IPI00488483 tdh Novel protein 0.30479 3.37287 2.208 0.40926 
12 15.94 59.47  IPI00503124 tuba8l Tubulin, alpha 8 like 0.31915 2.51189 1.19124 0.63096 
13 2 26.85  IPI00899114 si:ch211-262e15.1 forkhead box K2 isoform 2 0.31915 5.05825 4.01791 3.90841 
14 10.1 33.27  IPI00490140 nat10 N-acetyltransferase 10 0.32211 3.80189 2.80543 1.48594 
15 6.87 58.60  IPI00510559 rpl10 Ribosomal protein L10 0.32509 2.48886 1.1272 1.15878 
16 12 30.14  IPI00503297 fkbp9 Novel protein 0.33729 2.77971 1.24738 0.55976 




18 3.4 15.44  IPI00861743 - 143 kDa protein 0.35318 3.69828 1.24738 0.302 
19 9.2 33.79  IPI00897502 
ap1b1 Novel protein similar to vertebrate 
adaptor-related protein complex 1, beta 1 subunit 
0.36644 3.80189 1.31826 1.23595 
20 10 27.80  IPI00506979 zgc:110815 Zgc:110815 0.38371 1.10662 1.39316 1.59956 
21 10.05 36.17  IPI00801488 zgc:158138 Zgc:158138 protein 0.39446 2.208 1.19124 1.33045 
22 21.23 61.06  IPI00832173 sptbn1 spectrin, beta, non-erythrocytic 1 0.39811 1.97697 1.33045 1.90546 
23 4.14 43.49  IPI00512644 hnrnph1l Zgc:85960 0.40179 2.0893 0.94624 1.5417 
24 6.3 39.29  IPI00861611 arpc4;arpc4l Arpc4l protein 0.41305 2.77971 1.14815 1.20226 
25 2 25.68  IPI00503715 akt2 V-akt murine thymoma viral oncogene homolog 2 0.41687 2.22844 0.52966 0.02655 
26 6.08 46.67  IPI00487033 
ywhae2 Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, epsilon 
polypeptide 2 
0.42462 1.59956 0.51523 0.75162 
27 6 25.37  IPI00513225 si:ch211-12e1.4 Si:ch211-12e1.4 protein 0.43652 2.99226 0.57016 0.99083 
28 8.03 33.57  IPI00487186 
tars Novel prtoein similar to vertebrate threonyl-tRNA 
synthetase 
0.4529 2.01372 0.62517 0.46989 
29 12.21 36.20  IPI00495614 taldo1 Transaldolase 0.4529 2.05116 0.50582 0.11912 
30 28.64 47.06  IPI00508338 actn4 Actn4 0.46559 1.58489 0.34995 0.98175 
31 1.54 23.30  IPI00513520 rfx2 DNA-binding protein RFX2 0.46559 1.83654 0.7656 0.69183 
32 5.33 35.41  IPI00482450 
p4ha2 Procollagen-proline, 2-oxoglutarate 
4-dioxygenase (Proline 4-hydroxylase), alpha 
polypeptide 2 
0.46559 2.14783 1.13763 0.49204 
33 32.05 72.08  IPI00497676 vdac2 Voltage-dependent anion channel 2 0.47424 2.12814 1.43219 1.70608 
34 16.76 38.38  IPI00486574 hdlbp High density lipoprotein-binding protein 0.47863 1.78649 1.27057 1.08643 
35 6.54 63.41  IPI00962672 zgc:86841 Zgc:86841 0.48753 1.97697 1.87068 2.44343 
36 6.62 30.80  IPI00614245 naa15a NMDA receptor-regulated gene 1a 0.51523 1.78649 1.35519 0.30761 
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37 2 12.14  IPI00494963 
ptcd3 Pentatricopeptide repeat-containing protein 3, 
mitochondrial 
0.52481 1.51356 1.27057 1.92309 
38 14.04 62.92  IPI00493342 hibadhb 3-hydroxyisobutyrate dehydrogenase b 0.52966 1.59956 2.07014 1.57036 
39 6.92 32.78  IPI00509630 psmc4 proteasome 26S subunit, ATPase, 4 0.52966 1.87068 1.18032 1.38038 
40 2.01 44.68  IPI00508736 leo1 RNA polymerase-associated protein LEO1 0.53456 1.87068 0.91201 1.07647 
41 4 34.81  IPI00931145 LOC572231 hypothetical LOC572231 0.53456 1.33045 2.42103 1 
42 7.52 32.73  IPI00512269 ldha L-lactate dehydrogenase A chain 0.53951 1.95885 1.45881 2.12814 
43 2.27 37.58  IPI00480881 pgp phosphoglycolate phosphatase 0.53951 2.39883 0.96383 0.93756 
44 16.65 44.80  IPI00920207 gmps Guanine monphosphate synthetase 0.5445 1.6293 1.03753 1.44544 
45 6.72 21.82  IPI00492652 
LOC554685;LOC100151449;heatr1 HEAT 
repeat-containing protein 1 
0.54954 1.00925 0.58076 0.95499 
46 6.03 20.81  IPI00496921 
ppm1g Protein phosphatase 1G (Formerly 2C), 
magnesium-dependent, gamma isoform 
0.55463 0.79433 0.29107 0.7379 
47 7.6 18.95  IPI00931798 - 275 kDa protein 0.57016 1.38038 2.18776 1.78649 
48 6.22 28.31  IPI00829298 
pds5a Sister chromatid cohesion protein PDS5 
homolog A 
0.58076 1.45881 0.41305 0.79433 
49 20.13 41.11  IPI00509057 copa Coatomer protein complex subunit alpha 0.58614 1.70608 1.22462 1.43219 
50 4 36.90  IPI00510683 psma6l Proteasome subunit alpha type 0.58614 1.43219 1.15878 0.39446 
51 4 19.39  IPI00876724 zgc:171801 Zgc:171801 protein 0.59704 2.07014 1.77011 0.40179 
52 8.03 27.73  IPI00491150 
eif3m Eukaryotic translation initiation factor 3 subunit 
M 
0.60256 0.75162 0.46132 0.15849 
53 10.22 55.12  IPI00551909 psmb3 Proteasome subunit beta type 0.60256 1.78649 1.38038 1.40605 
54 8 57.36  IPI00817619 mapre1 29 kDa protein 0.60813 1.52757 1.18032 1.47231 
55 13.67 40.20  IPI00511624 
pcca Propionyl-Coenzyme A carboxylase, alpha 
polypeptide 
0.60813 1.59956 1.09648 1.40605 
56 2 34.88  IPI00486987 si:dkeyp-66g8.1 Novel protein similar to vertebrate 0.60813 0.6368 1.65959 0.82414 
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GATA zinc finger domain containing 2B 
57 8 40.92  IPI00614827 idh3g isocitrate dehydrogenase 3 (NAD+) gamma 0.61376 0.57544 1.07647 0.95499 
58 11.34 30.90  IPI00509051 kars Lysyl-tRNA synthetase 0.61376 1.47231 1.58489 0.98175 
59 19.73 38.89  IPI00772565 scinla Scinderin like a 0.61944 1.61436 1.18032 1.43219 
60 37.67 68.34  IPI00484639 
aldh1a2 Aldehyde dehydrogenase 1 family, member 
A2 
0.62517 1.55597 1.13763 0.40926 
61 6.82 25.88  IPI00485615 xpo1 exportin 1 0.62517 1.70608 1.21339 1.36773 
62 3.34 53.90  IPI00482496 tuba8l2;LOC100330913 Tubulin, alpha 8 like 2 0.63096 1.75388 1.33045 1.21339 
63 21.59 64.43  IPI00506192 ahcy Adenosylhomocysteinase 0.63096 1.97697 1.38038 0.83946 
64 17.73 30.92  IPI00502066 usp10 wu:fc76g05 isoform 1 0.63096 2.208 2.14783 1.45881 
65 2.38 21.04  IPI00481071 zgc:65870 Zgc:65870 0.63096 2.55859 2.48886 1.14815 
66 2.11 23.08  IPI00635460 zgc:153377 Zgc:153377 0.6368 1.55597 0.94624 1.20226 
67 2.92 33.45  IPI00482860 sf3a2 Splicing factor 3a, subunit 2 0.64269 1.65959 1.34276 2.31207 
68 2.43 32.12  IPI00508593 ppp2r5eb Protein phosphatase 2, regulatory subunit B 0.64269 2.0893 2.53513 0.11169 
69 2 49.80  IPI00963392 
LOC100332205 guanine nucleotide-binding protein, 
beta-4 subunit-like 
0.64269 0.96383 0.87096 0.24889 
70 10.86 34.36  IPI00490214 
LOC558088 Novel protein similar to vertebrate 
carnitine palmitoyltransferase 1A 
0.64269 1.5417 1.27057 1.55597 
71 7.52 39.53  IPI00611974 ddx21 Ddx21 protein 0.64269 1.7378 1.18032 1.05682 
72 8.23 35.48  IPI00511925 rpl3 Ribosomal protein L3 0.64269 1.40605 1.47231 1.75388 
73 15.82 59.50  IPI00490850 aldocb Fructose-bisphosphate aldolase C-B 0.64863 0.92045 0.60814 0.38019 
74 4 20.62  IPI00882984 zgc:174908 Zgc:174908 protein 0.66069 1.52757 1.75388 0.61944 
75 3 32.86  IPI00486869 
mhc1ufa Major histocompatibility complex class I 
UFA gene 
0.66069 1.0666 0.74473 1.51356 
76 3.6 54.30  IPI00769589 
LOC798846 Novel protein similar to vertebrate heat 
shock 70kDa protein 1B 
0.66069 1.77011 0.52 0.01675 
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77 12.01 38.38  IPI00932722 stip1 62 kDa protein 0.66681 1.11686 0.47424 0.73114 
78 8.7 66.67  IPI00504889 tbca Tubulin cofactor a 1.51356 0.55976 0.82414 0.53456 
79 86.21 38.23  IPI00631543 dync1h1 Dynein cytoplasmic 1 heavy chain 1 1.51356 1.02802 2.208 1.95884 
80 6.57 64.96  IPI00679292 zgc:123292 Zgc:123292 1.51356 1.24738 1.07647 0.33113 
81 38.71 64.81  IPI00483215 eno1 Enolase 1.51356 1.33045 1.0666 0.35975 
82 10.11 52.12  IPI00931220 wu:fd44a05 47 kDa protein 1.52757 0.84723 0.77268 0.46132 
83 28.46 45.02  IPI00506057 hsp90b1 Tumor rejection antigen (Gp96) 1 1.52757 0.58076 1.10662 1.28233 
84 52.68 55.48  IPI00865996 spna2 Alpha II-spectrin 1.5417 0.22909 0.6368 0.90365 
85 10.19 46.50  IPI00484953 api5 Apoptosis inhibitor 5 1.5417 0.53951 1.11686 1.48594 
86 7.52 38.82  IPI00508820 zgc:66306 Zgc:66306 1.5417 0.62517 0.99083 1.72187 
87 8 63.53  IPI00961203 
LOC100006097 transcription factor BTF3 homolog 
4-like 
1.5417 0.61376 0.68549 0.46559 
88 4.01 18.44  IPI00960584 wu:fb40g11 hypothetical protein LOC322006 1.57036 0.75858 0.48753 0.79433 
89 4 32.52  IPI00494766 rpl35 60S ribosomal protein L35 1.58489 0.4529 1.03753 1.5417 
90 5.75 25.36  IPI00510677 usp14 Ubiquitin carboxyl-terminal hydrolase 1.59956 0.41687 0.70469 0.87096 
91 5.43 30.38  IPI00504292 nsfl1c NSFL1 (P97) cofactor 1.59956 0.46132 0.44463 0.75162 
92 2.03 22.19  IPI00482344 zgc:55741 Zgc:55741 1.59956 0.7656 0.88716 0.55463 
93 2.1 19.91  IPI00501731 
pafah1b3 Platelet-activating factor acetylhydrolase, 
isoform Ib, gamma subunit 
1.61436 0.61376 0.91201 0.50119 
94 11.7 25.18  IPI00499072 eftud2 Eftud2 protein 1.61436 1.04713 0.8091 0.39084 
95 12.05 56.18  IPI00501560 
g3bp1 GTPase activating protein (SH3 domain) 
binding protein 1 
1.61436 0.56494 1.25893 1.21339 
96 8.01 36.46  IPI00961701 LOC100334924 neutral alpha-glucosidase AB-like 1.6293 0.58076 0.81658 0.2704 
97 4.32 28.53  IPI00656507 ktelc1 Zgc:123318 1.6293 0.58614 0.5445 0.63096 
98 4.01 33.42  IPI00860014 
LOC100334022 mitochondrial ribosomal protein 
L38-like 
1.6293 0.60814 1.44544 1.43219 
102 
 
99 15.97 43.36  IPI00481246 ctps CTP synthase 1.64437 0.90365 0.89536 0.40179 
100 5.4 35.97  IPI00758980 
atp1b1a ATPase, Na+\/K+ transporting, beta 1a 
polypeptide 
1.69044 0.71121 1.33045 0.1888 
101 1.4 17.51  IPI00902221 - 283 kDa protein 1.70608 1.38038 2.18776 0.55976 
102 4 29.96  IPI00486724 tmem48 Nucleoporin NDC1 1.77011 0.62517 0.81658 1.23595 
103 13.65 27.95  IPI00486103 cpne1 Copine III 1.87068 0.53456 1.08643 1.03753 
104 20.61 61.43  IPI00507046 
psmd3 Proteasome (Prosome, macropain) 26S subunit, 
non-ATPase, 3 
1.88799 0.75162 0.58614 0.49659 
105 2.36 25.24  IPI00500366 tcea1;tcea3 Transcription elongation factor A (SII), 1 1.92309 0.1406 0.60813 0.39084 
106 10.74 35.03  IPI00607441 ncl1 Isoform 2 of Nicalin-1 1.95885 0.44875 0.02754 0.00603 
107 25.81 77.74  IPI00512157 zgc:64133 Malate dehydrogenase 1.99526 0.12942 0.91201 1.2942 
108 11.89 43.80  IPI00932106 nop56 NOP56 1.99526 0.46559 0.74473 0.72444 
109 2.61 35.89  IPI00506479 pura Purine-rich element binding protein A 1.99526 0.67298 1.43219 1.51356 
110 2.23 28.24  IPI00618527 ubr5 LOC571063 protein 2.01372 0.46132 1.18032 0.47424 
111 19.17 49.93  IPI00487537 
mcm7 MCM7 minichromosome maintenance deficient 
7 
2.07014 1.01859 0.89537 0.2355 
112 13.33 42.39  IPI00570064 actr2b Actin-related protein 2-B 2.12814 0.64269 0.84723 1.80302 
113 22.31 68.46  IPI00483337 pl10 Putative RNA helicase 2.14783 0.78705 0.39446 0.52966 
114 2.84 34.59  IPI00851590 zgc:110695 ubiquitin-like protein FUBI-like 2.1677 0.70469 0.71779 0.1977 
115 52.39 36.20  IPI00972187 - 543 kDa protein 2.18776 1.27057 1.43219 0.56494 
116 34.96 60.12  IPI00506014 hspa9 Heat shock protein 9 2.22844 0.36983 0.88716 0.39811 
117 2 19.25  IPI00487156 capns1b Capns1b protein 2.29087 0.50582 0.5445 0.68549 
118 16 65.69  IPI00493442 rbm4.3 hypothetical protein LOC406277 2.31206 1.19124 0.7656 0.44055 
119 11.1 64.02  IPI00508226 ppia Peptidyl-prolyl cis-trans isomerase 2.33346 0.50119 1.1695 1.67494 
120 5.95 31.84  IPI00899082 LOC100151500 histone cluster 1, H1b-like 2.33346 0.5445 0.74473 1.10662 
121 3.66 23.25  IPI00611897 nsfa N-ethylmaleimide-sensitive factor 2.35505 0.34995 1.18032 0.05346 
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122 4.52 62.41  IPI00488350 cox5aa Cytochrome c oxidase subunit Vaa 2.48886 0.55976 0.68549 0.97275 
123 10.02 67.55  IPI00494738 rps13 Ribosomal protein S13 2.60615 0.31915 0.83176 0.05346 
124 3.5 42.10  IPI00491820 
hsp90a.2 Novel protein similar to heat shock protein 
90-alpha 
3.34195 0.36644 1.39316 0.55976 
125 3.28 28.87  IPI00829146 
zgc:158649 Novel protein with a Glycosyl hydrolase 
family 85 domain 
3.49945 0.4529 0.52481 0.42855 
126 8.99 24.76  IPI00829204 cnot1 CCR4-NOT transcription complex subunit 1 3.56451 0.3281 1.08643 0.4529 
127 15.4 40.91  IPI00920260 ncl Zgc:152810 4.36516 0.0492 1.00925 1.35519 
128 2.12 23.10  IPI00800843 sfxn4 Sideroflexin 4 5.39511 0.11272 0.59704 0.0263 
129 2.07 26.67  IPI00920704 sf1 18 kDa protein 7.51623 0.06982 1.33045 0.00146 
130 6.88 35.47  IPI00845912 zgc:123333 alpha-N-acetylgalactosaminidase 7.7983 0.05702 1.07647 0.0034 
131 7.54 32.10  IPI00482094 
si:ch211-251b21.1 Novel protein similar to G.gallus 
KBP, Kainate-binding protein 




In view of the previous results, during the infection process, the virus may trigger the shutoff 
of host cell macromolecular synthesis through special signaling pathways including many 
types of molecular elements. The eif3m (Eukaryotic translation initiation factor 3 subunit M) 
protein is a component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which 
is required for several steps in the initiation of protein synthesis (Pain. 1996). The eif3m was 
down regulated (0.60256) after SGIV infection. The eIF-3 complex associates with the 40S 
ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2 and eIF-5 to form the 43S 
preinitiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S 
PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for 
disassembly and recycling of posttermination ribosomal complexes and subsequently 
prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. Virus 
infections (FV3, herpes virus) may activate eIF kinase and increase the eukaryotic translation 
in host cells. The reduction of eIF-3 inhibitor’s expression, may increase the eIF-3 complex 
stimulating downstream RNA synthesis (Dong, Z., et al. 2006; Hinnebusch AG. 2006; 
Korneeva, N.L., et al. 2000; Park, H.S., et al. 2004; Pyronnet, S. et al. 2001; Sonenberg N et 
al., 2000). 
Obviously, the host cells metabolism and message degradation was also affected after virus 
infection. Ubiquitin carboxyl-terminal hydrolase (usp14) is a proteasome-associated 
deubiquitinase which releases ubiquitin from the proteasome targeted ubiquitinated proteins. 
This protein ensures the regeneration of ubiquitin at the proteasome (Hu M., et al., 2005; 
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Koulich E., et al., 2008; Mines M.A. et al., 2009; Nagai A. et al., 2009; Reuter T.Y., et al., 
2003; Rigbolt K.T. et al., 2011). It is a reversibly associated subunit of the proteasome and a 
large fraction of proteasome-free protein exists within the cell. This protein is up regulated 
after SGIV infection (iTRAQ radio 1.599558). Meanwhile the zgc:110695 protein 
(ubiquitin-like protein, FUBI-like) also up regulated (iTRAQ radio 2.1677041). Previous 
study in our lab has identified SGIV encoded ubiquitin-like protein by itself (SGIV 
ORF102L). To summarize, both of the host cell and virus can synthesize ubiquitin (or 
ubiqutitin-like protein) and the expression levels of these proteins were greatly increased after 
SGIV infection. These huge amounts of ubiquitin-like protein can help the pathogen to 
manage host cells metabolism by controlling specific proteins degradation. 
In the same time of inhibiting host cells synthetic functions, SGIV infection also results in the 
inhibition of apoptosis. Most viruses encode proteins that can inhibit apoptosis. Apoptosis is 
the process whereby individual cells of multicellular organisms undergo systematic 
self-destruction in response to a wide variety of stimuli. Apoptosis is a genetically controlled 
preprogrammed event which eliminates cells during development when they have become 
redundant or which functions as an emergency response after radiation damage, viral 
infection, or aberrant growth induced by the activation of oncogenes. In the case of 
virus-infected cells, the induction of early cell death would severely limit virus production 
and reduce or eliminate spread of progeny virus in the host. Thus, most animal viruses have 
evolved strategies to evade or delay early apoptosis to allow production of high yields of 
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progeny svirus (Teodoro, Branton., 1993). Our iTRAQ results were consistent with these 
studies. Apoptosis inhibitor 5 (api5) has been identified which presented a significant 
increase in infected host cell (as listed in Table 4. 4, iTRAQ ratio 114:113 is 1.5417). As the 
name suggests, api5 is an anti-apoptotic factor that may have a role in protein assembly 
(Gianfrancesco F. et al., 1999; Han B.G., et al., 2012; Kim J.W. et al., 2000; Krejci P., et al., 
2007; Sasaki H., et al., 2001; Taylor T.D. et al., 2006). Api5 negatively regulates ACIN1 
(apoptotic chromatin condensation inducer 1), by binding to ACIN1, it suppresses ACIN1 
cleavage from CASP3 (caspase 3, apoptosis-related cysteine peptidase) and ACIN1-mediated 
DNA fragmentation. This protein also known to efficiently suppress E2F1 (E2F transcription 
factor 1)-induced apoptosis.  
4.3.3 Identification of viral proteins by using iTRAQ  
In this study, 16 viral proteins in total have been identified in the 1
st
 run, and 28 in the 2
nd
 run. 
Only four of the 16 proteins’ total ion score C.I. % is larger than 95 % in the 1st run and 15 of 
28 is larger in the 2
nd
 run. There is no new protein has identified in these proteomics study.  
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NTPase OS=Singapore grouper iridovirus GN=ORF060R PE=4 SV=1 
Major capsid protein OS=Singapore grouper iridovirus GN=ORF072R PE=4 SV=1 
Ubiqutin/ribosomal protein OS=Singapore grouper iridovirus GN=ORF102L PE=4 SV=1 




Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF101R PE=4 SV=1 
Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF037L PE=4 SV=1 
Ubiqutin/ribosomal protein OS=Singapore grouper iridovirus GN=ORF102L PE=4 SV=1 
Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF156L PE=4 SV=1 
Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF020L PE=4 SV=1 
Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF091L PE=4 SV=1 
NTPase/helicase OS=Singapore grouper iridovirus GN=ORF146L PE=4 SV=1 
Putative immediate-early protein OS=Singapore grouper iridovirus GN=ORF086R PE=4 SV=1 
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Putative uncharacterized protein OS=Singapore grouper iridovirus GN=ORF162L PE=4 SV=1 
Major capsid protein OS=Singapore grouper iridovirus GN=ORF072R PE=4 SV=1 
Deoxynucleoside kinase OS=Singapore grouper iridovirus GN=ORF067L PE=4 SV=1 





The numbers of identified viral proteins were not as many as we expected, but the 
identified viral proteins include the three different stages (immediately early, early, 
and late stge) proteins by iTRAQ analyses. Compared with the SGIV infected grouper 
cells iTRAQ results, less viral proteins (49 viral proteins have been reported in the 
previous experiment) have been found in infected zebrafish cells. However, this result 
was consistent with the infectivity test described in Chapter 3.2. Zebrafish is not the 
original host of SGIV, although the mature virus can be assembled in the infected 
zebrafish cells, however, compared to the infected grouper cells, the number of 
mature virus was reduced. For this reason, the viral proteins amounts were also 
reduced in infected zebrafish cells. Less viral proteins have been translated in host 
cells, and these were hard to be recognized by iTRAQ analysis.  
The iTRAQ ratio of the viral proteins can be used to confirm the knockdown efficacy 
directly. In the 2nd run, the SGIV ORF086’s radio 118:114 (knockdown infection vs. 
control infection) is 0.679204, so the target gene is down-regulated after asMO 
treatment. It means less ORF086 have been detected in knockdown infected zebrafish 
cells, and the knockdown experiment was successful.  
SGIV genome has 162 predicted ORF’s, by now many of them still remained 
unknown. The advantage of iTRAQ analysis is to compare different treatments 
samples in a single reaction. However, it is not sensitive enough to identify the low 
abundant proteins, because the background of high abundant proteins may cover the 
signals of some rare proteins. And iTRAQ analysis is not the only method to 
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indentified viral proteins. It could be better combined with other proteomic 
approaches to recognize novel viral proteins.  
4.4 Discussion 
This experiment was the first report to study SGIV infected host cell protein 
expression alteration not using the grouper cell line. Meanwhile, it was also the first 
study of pathogen infected zebrafish cell line (complete sequenced genome) at 
proteomics scale. More than 3000 host proteins were identified and characterized by 
iTRAQ platform and downstream analyses. After further investigation, we also 
revealed numerous cellular proteins, being involved in RNA splicing, protein 
synthesis, energy metabolism and cell death, which are regulated during viral 
infection, giving critical information how the virus hijacks the host machinery for its 
replication.  
At the same time, to identify and characterize the zebrafish proteins, many novel 
proteins with unknown function were confirmed in this experiment. As an ideal 
biological model, these data can be used to establish the unique zebrafish protein data 
base. It will become an important reference to further study zebrafish protein network 
and biological evolution.  
It was also a pioneer study to evaluate the SGIV infected host cell using 8-plex 
iTRAQ. For this study, 8 different treatments were performed at the same time, which 
means three viral genes were knockdown simultaneously. Three viral genes from 
different stages have been evaluated in one analysis by 8-plex iTRAQ. In previous 
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study, only one viral gene can be knockdown in each analysis. This is an ideal 
condition to compare different viral genes function during SGIV infected host cells.  
However, there are also some weaknesses in this study need to be improved. First of 
all, the protein candidates’ numbers are very different between two runs. The initial 
purpose for this experiment is to find more host proteins which may be regulated in 
SGIV infection. However after the first run, the candidates with confidence were not 
as many as we expected. From the above data, it clearly showed that more host 
proteins have been identified in the second run, which may due to the different protein 
extraction method. In the first run the protein lysate was separated in SDS PAGE 
following by the in gel digestion. However in the second run the protein lysate was 
digested in solution directly. In one hand, the in gel digestion method has great 
advantage in providing a high purity of sample. The impure components may affect 
concentration measurement or even binding to iTRAQ-reagent and cause false 
positive signal in MS results. In certain types of samples, such as tissue or sample 
with high abundance of pigments, the in gel digestion is the only choice for iTRAQ 
sample preparation. In another hand, the in gel digestion method also has serious 
disadvantages, and one of them is sample loss. Because the SDS PAGE can only 
separate certain size of proteins, it is no doubt that this method limits the proteins size. 
For sure the in solution digestion method can solve this problem, because all the cell 
samples were lysed into eppendorf tube and carried to the subsequent preparation 
steps. The results were as we expected, more than one thousand host proteins (3473 
VS. 2284) were found in the second run with confidence compared to the first run.  
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The second problem was different ORF’s have been chosen to perform the 
knockdown experiments in two times running. In our previous reports, the ORF018R 
and ORF075R are two major capsid proteins in SGIV, so we choose both of these as 
our knockdown targets and performed the asMO transfection experiments. 
However, when the 1
st
 iTRAQ data was out, the knockdown ORF075R results were 
not as significant as we expected. The proteomic data were consistent with the 
functional study of these two proteins: the percentage of abnormal immature virus 
was higher in infected host cells by knockdown ORF018R than knockdown 
ORF075R. Due to this reason, in the 2
nd
 approach, we use ORF086, an immediate 
early stage gene instead of ORF075R. In this case the three knockdown targets were 
from three different stages during SGIV infection, so we can discuss the host proteins 
expression in various stages. 
In summary, the proteomics study provided vast valuable information for host cells 
response to SGIV infection. It can be used to further investigate SGIV infection 
mechanism and host-virus proteins-proteins interaction. What’s more, the 
improvement of sample preparation and proteomic techniques also can help the 















To further investigate the structure and function of ORF075R, we have attempted to 
purify the viral proteins and to crystallize the protein. First of all, study the ORF075R 
structure can help us to examine the function of the target protein. If we can figure out 
the protein binding site or catalytic subunit of ORF075R, then it will allow us to 
further detect protein-protein interaction with other viral or host proteins. What’s 
more, as one of the major capsid protein of SGIV, solving ORF075R structure can 
help us to improve the virus particle structure resolution by protein docking. Last but 
not least, study the structure of novel protein ORF075R is also a major challenge in 
protein structural study.  
5.2 Materials and methods 
5.2.1 E.coli strains and competent cells preparation 
Two different types of E.coli strains were used in this study: DH5α (Invitrogen) for 
cloning and BL-21 (Invitrogen) for protein expression.  
To prepare the competent cells, frozen glycerol stock of E.coli cells was streaked out 
and grown up on an LB agar plate (see Appendix) in a 37℃ incubator overnight. One 
single colony was picked up with an inoculation loop and cultured in 3 mL fresh LB 
medium (see Appendix) in a 37 ℃ shaker for overnight. 1 mL of this overnight 
cultured medium was transferred into 100 mL LB medium and cultured until O.D550 
~ 0.48. The cell was cool down in ice for 15 min and pelleted by centrifugation at 
5000 rpm for 5 min. The cell pellet was resupended in 40 mL pre-cool TfbI buffer 
115 
 
(see Appendix) and incubated on iced for 15 min, spun down again, resuspended in 4 
mL of pre-cool TfbII buffer (see Appendix) and kept on ice for another 15 min. The 
competent cells were used immediately or frozen by liquid nitrogen and stored at 
-80 ℃. The cells were thawed on ice just before use in a transformation experiment. 
5.2.2 Plasmids amplification and purification 
The following two types of plasmids were used in this study, and vector maps’ were 
attached in appendix: pET15b (Amersham Biosciences), pET28a-sumo (provided by 
Dr. Adam Yuan’s lab, sumo is cloned into pET28a vector between Nde I and BamH I). 
To amplify the target genes, plasmids were transformed into E.coli competent cell and 
amplified by inoculating a single colony in 3 mL of LB 100 μg/mL Amp medium at 
37 ℃overnight. Plasmid purification was carried out by using QIAprep Mini kit. 
5.2.3 Vector construction  
5.2.3.1 Gene cloning 
The target gene DNA sequence was amplified using Platium TagDNA polymerase 
High Fidelity (Invitrogen) from SGIV genomic DNA. Special designed primers which 
are adapted with restriction enzyme sites were used. The PCR reaction was performed 
by thermal cycler under manufacturer’s instruction. After that, the PCR products were 
purified using QIAquick PCR purification kit. 
In total 12 C-terminal truncated ORF075R constructs were established. Primers of all 
these constructs were showed in Table 5.1 
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Table 5.1 Primers of truncated ORF075R (N= non soluble, Y= soluble) 



















ORF075-21F CGCGGATCCGCCATCCCGTTGCACGAAAGG Y 
ORF075-23F CGCGGATCCCTCAGCGCCATCCCGTTGCAC Y 
ORF075-25F CGCGGATCCGATTTTGACGAGAACGTGGAA Y 
ORF075-27F CGCGGATCCGACAAAGAAAACCTCAGCGCC Y 
ORF075-29F CGCGGATCCCCAGATGACAAAGAAAACCTC Y 
ORF075-30F CGCGGATCCGTGGAAGGCGGCGATTACGCA Y 
ORF075-31F CGCGGATCCGAGTTTCCAGATGACAAAGAA Y 
ORF075-R2 CCGCTCGAGTTACGTCGATTTTCCGTGTCC   
 
5.2.3.2 Enzyme digestion 
The purified PCR products and vectors were digested by restriction enzymes (NEB). 
A 20 μL enzyme digestion reaction consisted of 2 μL of 10X BSA buffer, 0.2 μL of 
appropriate reaction buffer, 1 μL of each restriction enzyme, 1 μg of DNA and ddH2O 
top up to 20 μL. The mixtures were incubated at 37 ℃ for 2 hours following by 
QIAquick PCR purification kit purification. 
The digested mixtures were dephosphorylated by treating with 5 units of calf 
intestinal phosphatase ( NEB) at 37 ℃ for 1 hour. All reactions were terminated by 
incubation at 85 ℃ for 20 mins. Desired digested vectors were then excised from the 
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agarose gel and purified using QIAquick gel extraction kit. 
5.2.3.3 Ligation and transformation 
A ligation reaction contained 2 μL of 10X T4 ligase buffer, 1 μL of T4 ligase (20000 
U/ μL) (Promega), dephosphorylated PCR products and vector at ratio of 1: 3 and 
ddH2O added to a final volume of 20 μL. The mixture was incubated at room 
temperature for 30 min or 14 ℃ overnight and was ready to be transformed into 
competent cells. 
100 μL of aliquot competent cells were thawed and mixed with the ligation products 
on ice for 20 min. After heat shock at 42 ℃ for 60 sec, the cells were kept on ice for 
an additional 2 min. 800 μL LB medium was added to the cells. The mixture was 
gently inverted and incubated in a 37 ℃ shaker for 45 min. Then the cells were plated 
onto LB 100 μg/mL Amp agar plate and incubated at 37 ℃ for overnight. 
5.2.3.4 Sequence determination 
Clones grown on selected plates were picked up and inoculated in 3 ml LB 100 
μg/mL Amp medium at 37 ℃ and shaking overnight. The inserts of target gene was 
amplified using Tag PCR kit (NEB). PCR was carried out as manufacturer’s 
instruction. The PCR products were digested by selected restriction enzymes and 
separated on a 1.2% agarose gel. The positive clones, which showed the specific band 
with correct size on the gel, were selected for plasmid preparation using QIAprep spin 
mini prep kit. 
The purified plasmid products were used to run the cycle sequencing reaction. This 
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reaction was performed based on the standard protocol supplied by Applied 
Biosystems with minor modifications. Concentration of the recombinant plasmid was 
determined. The primers were specific designed base on the vector promoter. A 20 μL 
cycle sequencing reaction contained 4 μL of 5X sequencing buffer, 3.2 pmol of primer, 
2 μL of Terminator Ready Reaction Mix (BigDyeTM v3.1), 300 – 400 ng 
recombinant plasmids and ddH2O added. The cycle sequencing PCR started with (i) 
initial denaturation at 95 ℃ for 2 mins; (ii) 27 cycles of 96 ℃ for 30 sec, 50 ℃ for 15 
sec and 60 ℃ for 4 mins; (iii) final extension at 72 ℃ for 15 mins. 
The products of the cycle sequencing PCR were separately transformed to 1.5 ml 
eppendorf tubes and precipitated for 15 min standing at room temperature with 80 μL 
of ethanol/ sodium acetate solution (see appendix). DNA was pelleted after spun 
down at maximal speed for 20 min. To remove any trace of unincorporated dye and 
salts, DNA pellets were washed with 500 μL of 70% ethanol, kept for 15 min at room 
temperature, and spun down again at maximal speed for 5 min twice. The tubes were 
inverted and dried overnight at room temperature. 
Each cycle sequencing product was dissolved in 12 μL Hi-Di formamide and mixed 
with quick vortex. The tubes containing dissolved DNA fragments were transferred to 
a 96- well sample plate for PCR plate and covered with a transparent stick tape. 
Heated at 95 ℃ for 2 mins, the plate was placed into a 96- well rack and quickly 
centrifuged to bring the samples to the bottom of the wells. Prior to sequencing, the 
plate was placed on ice for 4 ℃. The sequencing was carried out with ABI PRISMTM 
3100 Genetic Analyzer.  
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5.2.4 Protein expression 
The plasmids which were inserted with correct target gene were transformed to BL-21 
strain E.coli cells for the following expression experiments.  
5.2.4.1 Small scale protein expression test 
To identify the optimal condition for specific protein production, a small scale test for 
protein expression was performed. A fresh single bacterial colony was inoculated with 
5 ml LB (2X YT) with antibiotic and incubated overnight at 37 °C with vigorous 
shaking (200 rpm) in a 15 ml sterile tube. Pre-warmed 50 ml LB (2X YT) medium in 
250 ml flask was inoculated with 1 ml of the overnight cultured bacteria, and 
incubated at 37 °C with shaking (180 rpm) until the OD600 reached 0.5 to 0.8 values. 
The cultured mixture was induced by IPTG with 1 mM final concentration. The cells 
were then grown for another 2-6 hrs or overnight depending on the temperature 
(15-37 °C). 1 ml of the sample was taken and pelleted down the cells. The cell pellets 
were lysed by sonication, and separated on a SDS-PAGE gel following visualized by 
Coomasie Blue staining to examine the levels of protein induction.  
5.2.4.2 Large scale protein expression in native condition 
The large-scale production of recombinant proteins from E. coli was carried out by 
culturing cells at the previously optimized conditions. 50 ml LB (2X YT) enriched 
media were inoculated with 50 μl cultured mixture as seeds overnight at 37 °C with 
shaking (200 rpm) in a 250 ml flask. 5 ml of the overnight culture were inoculated to 
1 L flasks with the desired medium containing an appropriate antibiotic (ampicllin or 
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kanamycin in different conditions), and incubated at 37 °C with shaking (180 rpm) 
until the OD600 reached 0.5 to 0.8. After that the cells were induced with 0.3mM IPTG 
(final concentration) and continually incubated overnight. Culture products were 
harvested by centrifugation at 8000rpm for 15 minutes at 4 °C. The cell pellets were 
purified immediately or frozen at -80 °C until further use.  
To lysis the cell pellets, ice-cold lysis buffer Z (1L cells for 50ml buffer Z, see 
appendix) was used to resuspend the pellets. The suspended cells were disrupted by 
sonicator for 20~30 minutes (1s on, 1 s off) on ice. The well lysed bacterial cells were 
centrifuged at16000~18000rpm for at least 30 minutes at 4 °C. And transfer the 
supernatant to a fresh tube carefully.  
The supernatant of last step was applied to 5ml His trap column on CU-960 (AKTA). 
Then the His column was washed with equilibrium buffer (see appendix) for 10-15CV 
(column volume) until the base line became smooth. After that the protein was eluted 
by elution buffer (see appendix) at different concentration of imidazole.  
To further purify the target proteins, ion exchange purification was performed. The 
approach can separate proteins base on the protein charge. In this study, SP column, a 
prepacked column with negatively-charged beads, was used. After binding, the bound 
proteins can be eluted by changing the ionic strength of elution buffer (gradient 
change of NaCl from 10mM to1M).  
Last step of this section is using Size exclusion chromatography (SEC) or Gel 
filtration chromatography (GFC) separates proteins based on their size. Purified 
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protein was injected to superdex 200 column, and the proteins were eluted with 
equilibrium buffer.  
The eluted proteins were determined by SDS-PAGE in all the steps which was 
discussed in 2.2.4. 
5.2.4.3 Large scale protein expression in denatured condition 
The bacteria were cultured, harvested, lysed and spun down as the same methods as 
native condition excepted using denature lysis buffer (see appendix). Then the 
recombinant HIS tag fusion protein was binded to Ni-NTA agarose beads (Qiagen). 
After that the proteins was washed with washing buffer for 10-15 CV and refolding 
by titrated the beads into pre-cool refolding buffer. The fusion protein was then eluted 
from the beads directly and subjected to SDS-PAGE analysis.  
5.2.5 Circular dichroism (CD) study 
The secondary structure of ORF075R was characterized by CD. ORF075R was 
prepared in 10~20mM sodium phosphate buffer, pH6.8. The experiment was 
conducted in the far UV range (190-260 nm) with Jasco spectropolarimeter J-720 at 
25 °C. 
5.2.6 Protein crystallization 
The following twenty-five crystal screening kits were used in this experiment. 
Crystal screen 1, Crystal screen 2, quick screen, CryoScreen, Index, AsMax, NaMax, 
PhosMax, MemMax, Natrix, pH clear suite, pH clear suiteII, Mb class suite, Mb class 
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suite II, MpdMax, PACT suite, CryoMax, Grid PEG6000, Protein complex suite, 
JCSG suite, Grid Screen Ammoinio Sulfate, Nucleix suite, ComPAS, Grid Screen 
NaCl, Anions. 
5.3 Results 
5.3.1 Secondary structure prediction of ORF075R  
The ORF075R is a novel virus protein with 178 amino acid residues, the MW of this 
protein is 19.96 Kd and pI is 4.5. Screening the sequence with BLAST showed that 
this protein has no conserved domain to any known proteins, and only has 
homologues in few close iridovirus species. Using online protein secondary structural 
prediction software, we detect that ORF075R has showed in Figure 5.1. The helix 




Figure 5.1 Secondary structure prediction of ORF075R  





5.3.2 Purification of full length ORF075R 
To express the target protein in vitro, ORF075R was cloned into pET-15b, and 
expressed in BL-21 strain. Figure 5.2 showed the purified target protein in 
SDS-PAGE. The solubility of the HIS-tag linked with full length ORF075R was very 
low in native condition. However the solubility was increased in denature condition, 
so we used denature method to purified the target protein. 
 
Figure5.2 Purification of ORF075R in SDS gel electrophoresis 
5.3.3 Circular dichroism (CD) study of denature purified full length ORF075R 
Circular Dichroism (CD) was performed to detect the secondary structure of 
ORF075R purified in denature conditions. The concentration of target protein was 
around 0.2 mg/ml, and the optimized buffer condition was phosphate buffer, at pH6.8.  
The result was showed in Figure 5.3. As can be seen, the salt concentration of the 
protein is in confidence interval and would not affect the protein secondary structure. 
And the target protein has a positive peak at 192 nm which means this protein should 
contain α helix structure. This result is consistent with the previous secondary 
structure prediction (Figure 5.1). We were not sure whether this protein hasβsheets 
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structure, it may due to the low percentage ofβsheets structure.  
From this result, we demonstrated that the in vitro purified ORF075R has the 
biological structure and can be used in following structure study. However, the 
denatured purified ORF075R was not stable even in 4 °C. We tried to use this product 











5.3.4 Purification of truncated ORF075R  
Due to the poor stability of the full length ORF075R, we tried to purify the truncated 
ORF075R instead. Considering the poor solubility of the HIS-tag, we used SUMO-tag 
to improve the protein solubility. 
5.3.4.1 Primers design 
We truncated ORF075R from the C-terminal of this protein. In total 12 constructs 
were established. (Primers of these constructs were showed in Table 5.1 in previous 
section) 
5.3.4.2 Protein expression 
In the first batch, we constructed truncated ORF075R vector in every 5 amino acids (5, 
10, 15, 20, and 25), and used the small scale expression to test the solubility. 
The ORF075R-25 (truncated at N-terminal 43
th
 amino acid) was the first truncated 
construct which can solve in lysis buffer. We purified this protein under native 
condition. And the SUMO-tag was removed from ORF075R-25 by sumo protease 





Figure5.4 Purification of ORF075R-25 in SDS gel electrophoresis 
5.3.5 Protein crystallization 
The protein purified in 5.3.3 was used to do the crystal screening. In a total of 25 
different crystal kits with 1200 different conditions were screened. The protein 
concentration was 10 ug/ul. The crystal plates were incubated in 20°C and checked 
every 2 days.  
After 2 weeks of screening, one of these conditions yielded tiny protein crystals, as 
showed in Figure 5.5, although the buffer was not very clear, which means the target 
protein was precipitated in this condition. ORF075R-25 yielded many crystals in 
precipitation. To optimize the buffer condition, we adjusted the protein concentration 
(5ug/ul 10ug/ul), buffer pH (5.7—6.3) and the sulfate concentration (1.7—2.4M). 
However, there was no significant improvement.  
So we decided to constructed the second batch of truncated ORF075R, for this time, 
we constructed every 2 amino acids (as showed in Table 5.1). All of these constructs 
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were soluble. But they were not stable after removed of the SUMO-tag. We carried 
out the crystal screening of these proteins with the SUMO-tag. The results were not 
positive. After 10 to 14 days growth, there were only few conditions generated tiny 
crystals for different constructs. However, similar to the ORF075-25’s results, even 















Figure 5.5 Crystal of ORF075R truncated  
A) Buffer condition: Wizard™ I No.23, 15% (v/v) ethanol, imidazole pH 8.0, 
0.2M MgCl2. Protein concentration: 10 ug/ul. B) Buffer condition: Phos max kit, 
condition No.46, 0.1M phosphate buffer pH=6.0 2M ammonium sulfate. Protein 
concentration: 10 ug/ul. C) Buffer condition: Cryomax kit, condition No.25, 0.2M 
MgCl2 pH=5.5 40% PEG550. Protein concentration: 10 ug/ul D) Buffer condition: 
Cryomax kit, condition No.63, 0.5M Ammonium Sulfate 0.1M Tris, pH=7.0 30% 
Propylene glycol. Protein concentration: 10 ug/ul    
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5.4 Discussion and future work  
In this study, we successfully cloned the ORF075R gene to different vectors and 
express the target protein in vitro. ORF075R can be purified in both native and 
denature conditions via different vectors. The purified protein has been demonstrated 
that has the secondary structural by CD analysis. And we also successfully got the 
target protein crystallization in few conditions. Although the crystals’ size are not 
enough to do the X-ray diffraction, newly techniques such as screening of proteins for 
crystallization under laser irradiation can be use in future study. We believe this 
problem can be solved. What's more, the purified virus protein can be further used in 















6.1 General conclusion 
In this thesis, we focused on the functional and structural study of novel SGIV 
proteins, and revealed several significant functions of these proteins in SGIV infection 
mechanism and virus-host interaction. 
The novel structural SGIV protein ORF075R was involved in virus genome 
packaging and viral particle assembly. Another SGIV structural protein ORF018R 
should be one of its binding partners. The subcellular localization and western blot 
results indicated that they have similar functions by cooperation in the cytoplasm of 
the host cells. 
In addition, we characterized that the post translational modification of ORF075R was 
due to phosphorylation. The phosphorylation of ORF075R in infected GEC was a 
continuous process. The process reveals that ORF075R expression is undergoing a 
dynamic change in infected GEC. The multiple phophorylation residues may be 
essential for virus genome replication and virion assembly. 
Another significant discovery was using proteomic approach (iTRAQ) to investigate 
the effects of different knockdown on virus and host proteins expression levels in 
zebrafish cells. The proteomics study provided vast valuable information for host cells 
response to SGIV infection. It was the first report to study SGIV infected host cell 
protein expression alteration not using the grouper cell line. Meanwhile, it was also 
the first study of pathogen infected zebrafish cell line (complete sequenced genome) 
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at proteomics scale. 
Last but not least, to study the structure of target protein, we successfully cloned the 
ORF075R gene to different vectors and express the target protein in vitro. Although 
the crystals’ size are not large enough for X-ray diffraction, we believe in future study 
this problem can be solved.  
Generally, this project outcome has contributed to understanding of SGIV proteins 
function and proteomics in virus and host cells. 
6.2 Future experiments 
6.2.1 Functional study of SGIV ORF075R 
To further study the function of ORF075R, the interaction of ORF075R and 
ORF018R may become a promising point. Monoclonal antibody of the targets protein 
can be raised and used in future experiments such as coIP, to further investigate the 
protein-protein interaction. 
In addition, the expression profiles and post translational modification of ORF075R 
gave us many useful clues to further investigate ORF075R host protein interaction. In 
future experiment, STK and HK should be the good candidates of ORF075R binding 
partners. And directed mutagenesis may be a good method in further study, as the 
phosphorylated residues were already recognized, we can replace these residues by 
other amino acids (alanine for example). To observe the defect of the mutagenesis 
protein could help us discover the specific function of ORF075R. 
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6.2.2 Proteomic study and virus-host interaction 
Three SGIV proteins from different stages were knocked-down in this project. The 
protein candidates found in this study can be used to further investigate SGIV 
infection mechanism and host-virus proteins-proteins interaction. Zebrafish cell as a 
new type of SGIV host cell also can be used in study the virus infection mechanism. 
What’s more, the improvement of sample preparation and proteomic techniques also 
can help the researchers doing the protein function and quantification study in future.  
6.2.3 Structural study of SGIV ORF075R  
In additional study the structure of ORF075R, new truncated vectors from C-terminal 
of ORF075R will be constructed. And to increase the possibility of protein 
crystallization, newly technique screening of proteins for crystallization under laser 
irradiation will be used in this study. These two approaches may help us to get larger 
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pET15b (Amersham Biosciences), pET28b(Novagen), pET28a-sumo (provided by 
Prof. Yuan Yuren’s lab, sumo is cloned into pET28a vector between Nde I and BamH 




Luria- Bertani (LB) medium and agar plate 
LB broth (per liter) 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 10g 
Bacto-yeast extract 5g 
NaCl 10g 
Dissolve solutes. Adjust pH to 7.0 with 1 M NaOH.  
Adjust volume to 1L with MQ H2O. 




For LB agar plates, the medium was supplemented with 15 g/L agar and sufficient 
amount of appropriate antibiotics (if required). 
 
Ampicillin (Amp) 
1 g of Ampicillin was dissolved in 10 ml of autoclaved MQ H2O to get a final 
concentration of 100 mg/ml. The stock solution was sterile- filtered through 0.22 μm 
membrane and stored in aliquots at -20 ℃ until use. The stock solution was diluted 1 : 
1000 when added to the medium. 
 
Tfb I (per liter) 






Adjust pH to 5.8 with dilute acetic acid, add MQ H2O to 1 L and autoclave. 
 
Tfb II (per liter) 





Adjust pH to 6.5 with 1 M NaOH, add MQ H2O to 1 L and autoclave. 
 
Ethanol/ sodium acetate solution 
3M Sodium Acetate pH5.2 3 μl 
Ethanol   62.5 μl 
ddwater 14.5 μl 
 
Lysis buffer (buffer Z) 
25 Tris pH 7.5 
25Mm Potassium Phosphate pH6.8 
500 mM NaCl  
10% Glycerol 
1 mM DTT 
 
Equilibrium buffer 
10mM Tris pH7.5 
250 mM NaCl  





10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 25mM imidazole  
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 250mM imidazole  
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 500mM imidazole  
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 750mM imidazole  
(Different concentration of imidazole were used depending on the binding ability) 
 
Denature lysis buffer 
8 M Urea  
100 mM Na2HPO4-NaH2PO4 
10 mM Tris-HCl pH 8.0 or 6.3  
10 mM Beta-Mercaptoethanol (add fresh at time of use)  
0.2% or 0.1% Triton X-100 
 
